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Abstract	(Italiano)	
L'attività di ricerca di questa tesi si concentra sulla rilevanza che modelli 
appropriati che riproducono il microambiente tumorale in vivo sono 
essenziali per migliorare le nostre conoscenze sul cancro e per testare nuovi 
composti antitumorali. I modelli animali hanno dimostrato non essere del 
tutto compatibili con il sistema umano, e le percentuali di successo tra gli 
studi su animale e su uomo sono ancora insoddisfacenti. D'altra parte, le 
colture cellulari 2D non riproducono alcuni aspetti del sistema tumorale. 
Queste limitazioni hanno un peso significativo soprattutto durante lo 
screening di nuovi farmaci, poiché è stato dimostrato che le cellule sono 
meno sensibili ai trattamenti se a contatto con il loro microambiente. Per 
ottenere gli stessi livelli di inibizione delle cellule tumorali osservati in 
vivo, l'ambiente di coltura deve dunque riflettere l'ambiente naturale 3D. In 
questo contesto, idrogel naturali o sintetici hanno riportato risultati positivi 
nell'imitare l'ambiente ECM. 
Durante questo dottorato, ho sviluppato diversi scaffold basati su gel da 
utilizzare come substrati per la coltura di cellule di cancro al seno. In 
dettaglio, ho sviluppato diversi gel per linee cellulari tumorali a bassa ed 
alta aggressività (i.e. MCF-7 e MDA-MB-231), ottenendo risultati 
significativi per quanto riguarda la riproduzione di caratteristiche chiave 
normalmente presenti nell'ambiente in vivo. Considerando l'importanza del 
processo di metastasi nell'evoluzione del cancro al seno, mi sono poi 
concentrata su un nuovo set-up per l'osservazione della motilità e 
dell'invasione delle cellule tumorali. In particolare, ho unito un approccio 
bioingegneristico basato su bioreattore con l'analisi a singola cellula di 
cellule tumorali circolanti (CTCs). Questa parte del lavoro è stata svolta 
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presso il Dipartimento di Biomedicina dell'Università di Basilea (CH) che, 
tra le sue facilities, ha un apparecchio per l'analisi di singole cellule. 
Alla fine di questo lavoro, ho fornito una proof-of-concept che l'approccio 
può funzionare, oltre a dimostrare che le cellule possono essere estratte dal 
dispositivo e utilizzate per l'analisi molecolare.		
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Abstract	(English)	
The activity of research of this thesis focuses on the relevance that 
appropriate models reproducing the in vivo tumor microenvironment are 
essential for improving cancer biology knowledge and for testing new 
anticancer compounds. Animal models are proven not to be entirely 
compatible with the human system, and the success rates between animal 
and human studies are still unsatisfactory. On the other hand, 2D cell 
cultures fail to reproduce some aspects of tumor system. These limitations 
have a significant weight especially during the screening of novel 
antitumor drugs, as it was demonstrated that cells are less sensitive to 
treatments when in contact with their microenvironment. To obtain the 
same tumor cell inhibition levels observed in vivo, the culture environment 
has to reflect the 3D natural environment. Natural or synthetic hydrogels 
reported successful outcomes in mimicking ECM environment. 
During this PhD, I developed different gel-based scaffolds to be use as 
substrates for the culture of breast cancer cells. In detail, I developed 
different gels for low and highly aggressive cancer cell lines (i.e. MCF-7 
and MDA-MB-231), obtaining significant results as regards the 
reproduction of key features normally present into the in vivo environment. 
Considering the importance of the metastasis process in breast cancer 
evolution, I then focused on a new set-up for the observation of cancer cell 
motility and invasion. In particular, I combined a bioreactor-based 
bioengineering approach with single cell analysis of Circulating Tumor 
Cells (CTCs). This part of work was carried out at the Dipartiment of 
Biomedicine of the University of Basel (CH) that, among its equipment, 
has a cell celector machine for single cell analysis. 
At the end of this work, I provided a proof-of-concept that the approach can 
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work, as well as evidence that the cells can be extracted from the device and 
used for molecular analysis. 
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Chapter	1	
2 Introduction	
1.1	Breast	cancer	
Cancer is a broad term for a class of diseases characterized by abnormal 
cells that grow and invade healthy cells in the body. Breast cancer occurs 
when malignant tumors develop in the breast. Breast cancer is the most 
common cancer in women across most ethnic groups and one of the leading 
causes of cancer-related deaths worldwide. 
 
A healthy female breast is made up of 12–20 sections called lobes. Each 
of these lobes is made up of many smaller lobules, the gland that produces 
milk in nursing women. Both the lobes and lobules are connected by milk 
ducts, which act as stems or tubes to carry the milk to the nipple. 
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Figure 1.1: Physiology of healthy breast, with lobules and milk ducts. 
These breast structures are generally where the cancer begins to form. 
Cancers developing from the ducts are known as ductal carcinomas, while 
those developing from lobules are known as lobular carcinomas [1].   
Invasive ductal carcinoma (IDC), sometimes called infiltrating ductal 
carcinoma, is the most common type of breast cancer. About 80% of all 
breast cancers are invasive ductal carcinomas. 
Invasive means that the cancer has “invaded” or spread to the 
surrounding breast tissues. Ductal means that the cancer began in the milk 
ducts, which are the “pipes” that carry milk from the milk-producing 
lobules to the nipple. Carcinoma refers to any cancer that begins in the skin 
or other tissues that cover internal organs — such as breast tissue. All 
together, “invasive ductal carcinoma” refers to cancer that has broken 
through the wall of the milk duct and begun to invade the tissues of the 
breast. Over time, invasive ductal carcinoma can spread to the lymph nodes 
and possibly to other areas of the body. 
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Figure 1.2: Differences between localized DCIS (ductal carcinoma in situ) 
and invasive cancer. 
Most studies divide breast cancer into 4 major molecular subtypes: 
• Luminal A 
• Luminal B 
• Triple negative/basal-like 
• HER2 type 
 
Luminal A 
Luminal tumor cells look the most like cells of breast cancers that start 
in the inner (luminal) cells lining the mammary ducts. 
Luminal A tumors tend to be: 
Ø Estrogen receptor-positive (ER-positive) 
Ø HER2 receptor-negative (HER2-negative) 
Ø Tumor grade 1 or 2 
About 30-70 percent of breast cancers are luminal A tumors. 
Of the 4 subtypes, luminal A tumors tend to have the best prognosis, 
with fairly high survival rates and fairly low recurrence rates. 
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Luminal B 
Luminal B tumors tend to be ER-positive. They may be HER2-negative 
or HER2-positive. Women with luminal B tumors are often diagnosed at a 
younger age than those with luminal A tumors. 
Compared to luminal A tumors, they also tend to have factors that lead 
to a poorer prognosis including: 
Ø Poorer tumor grade 
Ø Larger tumor size 
Ø Lymph node-positive 
About 10-20 percent of breast cancers are luminal B tumors. 
Women with luminal B tumors tend to have fairly high survival rates, 
although not as high as those with luminal A tumors. 
 
Triple negative/basal-like 
Triple negative breast cancers are: 
Ø Estrogen receptor-negative (ER-negative) 
Ø Progesterone receptor-negative (PR-negative) 
Ø HER2-negative 
There are several subsets of triple negative breast cancer. One subset is 
basal-like. Basal-like tumors have cells that look similar to those of the 
outer (basal) cells surrounding the mammary ducts. 
Most triple negative tumors are basal-like and most basal-like tumors are 
triple negative. However, not all triple negative tumors are basal-like and 
not all basal-like tumors are triple negative. 
About 15-20 percent of breast cancers are triple negative/basal-like. 
These tumors tend to occur more often in younger women and Black/non-
Hispanic black/African-American women (more on race/ethnicity and 
subtypes of breast cancer). Triple negative/basal-like tumors are often 
aggressive and have a poorer prognosis compared to the ER-positive 
subtypes (luminal A and luminal B tumors). However, they can be treated 
successfully. 
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HER2 type  
About 5-15 percent of breast cancers are HER2 type.  
HER2 type tumors tend to be:  
Ø ER-negative  
Ø PR-negative  
Ø Lymph node-positive  
Ø Poorer tumor grade  
Women with HER2 type tumors may be diagnosed at a younger age than 
those with luminal A and luminal B tumors.  
HER2 type breast cancers that are HER2-positive can be treated with 
anti-HER2 drugs such as trastuzumab (Herceptin). Before these drugs were 
available, HER2 type tumors had a fairly poor prognosis. 
1.2.	Mechanisms	of	metastasis	
Mortality for breast cancer is more associated to the development of 
metastases - the spread of a tumor from its primary site to other parts of the 
body - than to symptoms strictly related to the main lesion [2,3]. Thus, a 
deeper understanding of the pathways that give rise to metastasis is one of 
the key challenges for developing new therapies to fight breast cancer [3-
5]. 
Firstly, cancer cells can invade neighbouring healthy tissue. Following 
this, the cancer cells then invade local lymph nodes or blood vessels. 
The inherent characteristics of the lymphatic physiology serve as the 
primary route for tumor cell metastasis. The increasing size of the tumor 
triggers a rise in the intratumoral interstitial fluid pressure, and interstitial 
fluid is released as the system attempts to achieve homeostasis. Unlike the 
vascular vessels, the lymphatic vessels are highly permeable; the flow rate 
is approximately 100–500x slower, and coupled with lesser shearing 
stresses due to vasodilation. Therefore, the lymphatic route is superior in 
facilitating tumor cell dissemination. Distinguishing between lymphatic 
endothelial and systemic endothelial cells via immunohistochemical 
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staining has allowed studies to confirm tumor cell dispersion via afferent 
lymphatics and lymphangiogenesis, and implicates the lymphatics as the 
most significant metastatic route. 
 
Metastasis is a complex and inefficient process, which requires 
sequential regulation of a number of biological steps prior to the 
presentation of overt disease. This involves tumor cell dissociation, 
angiogenesis of the primary tumor, intravasation, survival and diffusion 
through the systemic and lymphatic circulation, adhesion to organ walls, 
extravasation, establishment of metastatic foci at the organ parenchyma, 
and finally, manifestation of clinically apparent metastasis via the 
generation of secondary tumors.  
 
 
Figure 1.3: Schematic representation of metastasis mechanism 
Different sub-processes acting at the cellular level guide each of these 
steps: several key stages of metastasis - including invasion, intravasation, 
and extravasation - are thought to involve ExtraCellular Matrix (ECM) 
degradation and remodelling [6]. Cancer cells contribute to matrix 
degradation through actin-rich subcellular protrusions known as 
invadopodia [7]. Invadopodia consists of an actin-rich core surrounded by a 
number of important protein components, including cytoskeletal 
		 13	
modulators, adhesion proteins, scaffolding proteins, and signaling 
molecules [8]. 
A salient aspect of metastasis is the potential of many tumor types to 
preferentially colonize various organs. Breast cancer cells possess an 
organ-specific pattern of dissemination and metastasize to bone (47–60%), 
and subsequently to the liver (19–20%), lung (16–34%), and brain (10–
16%). The tumor cells migrate from the primary tumor to the sentinel 
lymph node. However, no direct lymphatic routes to the preferred target 
organs have been identified, therefore the tumor cells eventually exit via 
the efferent lymphatic vessels and utilize the venous system or the nascent 
blood vessels that serve lymph nodes to merge with the systemic 
circulation. While this was previously considered to be a passive process, 
studies have revealed that chemokine receptors C-X-C chemokine receptor 
type 4 and C-C chemokine receptor type 7 are overexpressed in organs that 
are primary targets for metastasis (liver, bone and lungs), and may promote 
migration of their ligands, C-X-C motif chemokine 12/stromal cell-derived 
factor 1α and chemokine (C-C Motif) ligand 21. Additionally, studies have 
suggested that the primary tumor secretes vascular endothelial growth 
factor (VEGF) A and other soluble factors to define a pre-metastatic niche 
in the target organs, thereby demarcating where the tumor cells should 
preferentially metastasize. 
 
 
Figure 1.4: Schematic representation of last steps of metastasis: homing 
and colonization. 
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1.3.	State	of	the	art	
1.3.1.	2D	models	
Traditionally, cancer biology research has involved in vitro analysis of 
cell behavior predominately using two-dimensional (2D) cell cultures and 
in vivo animal models [9,10]: in detail, 2D models are routinely used as 
initial systems for evaluating the effectiveness of molecules as potential 
therapeutic drugs; this initial screening precedes animal studies before 
advancing to human clinical trials [11]. 
The dissimilarities in cell behaviour between 2D cultures and real 
tumours are well known and they mainly derive from changes in gene 
expression originated from the different interactions to which cells are 
subjected within a 2D microenvironment if compared to a more natural 3D 
[12,13]. A striking example of that is represented by the unequal nutrient 
concentration to which cells are exposed: in 2D cultures cells are uniformly 
exposed to nutrients, while in vivo the concentration of soluble factors 
influencing cell proliferation is characterized by spatial gradients that play 
a vital role in biological differentiation, organ development and countless 
other biological processes [14,15]. 
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Figure 1.5: Different interactions between cells and substrates (2D versus 
3D). 
Non-malignant as well as malignant mammary cells have typically been 
studied as monolayer cultures on tissue culture plastic in the absence of 
proper ECM thereby losing their tissue-specific function and morphological 
organization. It is, therefore, not surprising that many aspects of mammary 
biology and tumorigenesis are still not fully understood.  
 
1.3.2.	Animal	models	
Animal models have not been validated as a necessary step in 
biomedical research in the scientific literature. Instead, there is a growing 
awareness of the limitations of animal research and its inability to make 
reliable predictions for human clinical trials. Indeed, animal studies seem to 
overestimate by about 30% the likelihood that a treatment will be effective 
because negative results are often unpublished. Similarly, little more than a 
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third of highly cited animal research is tested later in human trials. Of the 
one-third that enter into clinical trials, as little as 8% of drugs pass Phase I 
successfully.  
 
 
Figure 1.6: Main current preclinical models (in vivo animal models). 
The major pre-clinical tools for new-agent screening prior to clinical 
testing are experimental tumors grown in rodents. Although mice are most 
commonly used, they are actually poor models for the majority of human 
diseases. Crucial genetic, molecular, immunologic and cellular differences 
between humans and mice prevent animal models from serving as effective 
means to seek for a cancer. Among 4000+ genes in humans and mice, 
researchers found that transcription factor binding sites differed between 
the species in 41% to 89% of cases [14]. 
 
In many cases, mouse models serve to replicate specific processes or 
sets of processes within a disease but not the whole spectrum of 
physiological changes that occur in humans in the disease setting [15]. 
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Figure 1.7: Different steps of cancer process that should be modeled in an 
ideal model (white arrow), versus processes actually modeled by real 
models (gray arrows). 
The failure to translate from animals to humans is likely due in part to 
poor methodology and failure of the models to accurately mimic the human 
disease condition. The core of the problem may be rooted in the animal 
modeling itself. Unlike in human clinical trials, no best-practice standards 
exist for animal testing [14]. Moreover, the laboratory environment can 
have a significant effect on experimental results, as stress is a common 
factor in caged mice [16]. It has been recommended that therapeutic agents 
should not only be evaluated in rodents, but also in higher animal species, 
and that randomization and outcomes assessor blinding should be 
performed. In addition, experiments should be designed in both genders 
and in different age groups of animals and all data, both positive and 
negative, should be published [3]. 
Despite the general lack of success in translating animal models to 
clinical studies, animals are still prevalently used in laboratories all over 
the world to test the safety, toxicity and effectiveness of drugs [17]. Animal 
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models have been essential in cancer research for obvious practical and 
ethical concerns associated with human experimentation. Animal research 
is similar to in vitro assays, epidemiological investigations, and computer 
simulations. All attempt to derive probabilistic knowledge in one context 
that will generalize to humans. All are forms of modeling that will map 
onto the whole population with less than perfect precision and predict with 
even less precision the fate of any individual. Notwithstanding, these 
methods risk missing some important knowledge, or risk finding 
knowledge that doesn’t hold up in the clinical setting even to a point that is 
actually harmful once widely deployed. 
 
1.3.3.	Alternative	in	vitro	models	
A wide range of alternatives to animal-based preclinical research has 
emerged. These include epidemiological studies, autopsies, in 
vitro studies, in silico computer modelling, “human organs on a chip” - 
creating living systems on chips by mimicking a micro-biological 
environment with cells of a certain organ implanted onto silicon and plastic 
chips [18], and “microfluidic chips” - automation of over a hundred cell 
cultures or other experiments on a tiny rubbery silicone integrated circuit 
with miniscule plumbing [19]. The National Institutes of Health of the 
United States suspended all new grants for biomedical and behavioural 
research on chimpanzees after an expert committee concluded that such 
research was unnecessary [20]. Furthermore, the US National Research 
Council recommends that animal model based tests be replaced as soon as 
possible with in vitro human cell-based assays, in silico models, and an 
increased emphasis on epidemiology [21]. Of particular interest in this 
context are the alternative in vitro models, in detail 3D cell cultures and 
microengineering technologies. 
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3D cell culture  
To understand fully how tissues form and function, as well as their 
pathophysiology, it is crucial to study how cells and tissues behave as parts 
of whole living organs that are composed of multiple, tightly opposed 
tissue types that are highly dynamic and variable in terms of their 3D 
structure, mechanical properties and biochemical microenvironment. 
Unfortunately, most studies on cell and tissue regulation have relied on 
analysis of cells grown in 2D cell-culture models that fail to reconstitute 
the in vivo cellular microenvironment; as a result, these cultures commonly 
do not maintain their differentiated functions.  
Efforts to address these limitations led to the development of 3D cell-
culture models in which cells are grown within extracellular matrix (ECM) 
gels. This approach enhances expression of differentiated functions and 
improves tissue organization [1]. Nevertheless, even the most impressive 
3D culture models fail to reconstitute features of living organs that are 
crucial for their function, including tissue–tissue interfaces (e.g. between 
epithelium and vascular endothelium), spatiotemporal gradients of 
chemicals and oxygen, and the mechanically active microenvironment that 
are central to the function of virtually all living organs. Gel-based culture 
systems also pose major technical challenges in terms of probing effects of 
physiological diffusion gradients (e.g. ion transport in kidney) or sampling 
cellular products that are often secreted in a polarized manner (e.g. biliary 
flow in the liver) because these tissues form in the center of the gel. As a 
result of these shortcomings of the existing 2D and 3D culture systems, 
systems-level analysis of cell and disease processes remains largely 
dependent on time-consuming and costly animal studies. However, as the 
pharmaceutical industry has come to discover, results obtained in animal 
experiments often fail to predict human responses.  
 
Microengineering technologies 
Development of microengineering approaches has opened entirely new 
possibilities to create in vitro models that reconstitute more complex 3D 
organ-level structures and to integrate crucial dynamic mechanical cues as 
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well as chemical signals. To study polarized functions of various epithelial 
cells (e.g. intestine, lung, kidney, cornea), for example, two PDMS cell-
culture chambers were stacked and separated by a permeable synthetic 
membrane or ECM. A similar approach has been used to integrate liver 
epithelium with microfabricated vascular networks [22], and fibroblasts 
were included as well in another liver model [23]. In this manner, 
microfabrication was leveraged to reconstitute a tissue–tissue interface that 
is a crucial element of whole liver organ structure, which was not 
previously possible in conventional 3D ECM gel cultures.  
Replica-molding techniques also have been used to replicate complex 
surface relief patterns to produce biomimetic structures that mimic organ-
specific microarchitecture. Microfabricated structures were built within 
microfluidic channels that resemble the endothelium that separates 
hepatocytes from the liver sinusoid in whole liver, with the goal of more 
closely approximating the mass transport properties of the hepatic 
microcirculation [24]. This bioinspired liver-on-a-chip enabled primary 
human hepatocytes to maintain liver-specific met- abolic activity for one 
week in culture without exogenous ECM coatings, and it induced formation 
of hepatic cord-like structures with functional bile canaliculi [25]. An array 
of PDMS microchambers interconnected by narrow (1 mm wide) channels 
was similarly used to enable growth and in vivo-like reorganization of 
osteocytes in a 3D environment that replicates the lacuna–canalicular 
network of bone [26]. Other examples include a compartmentalized 
microfluidic system that enables co-culture of neurons and 
oligodendrocytes to study neuron–glia communication during develop- 
ment of the central nervous system [27] and a microdevice incorporating 
ECM gels microinjected between two parallel microchannels to investigate 
the vascularization of liver tissues in 3D culture microenvironments [28].  
Similar microsystems approaches have been used to develop disease 
models. For example, a microfluidic co-culture platform was developed 
that allows for communication between different tissue types through 3D 
ECM gels to examine capillary-cell invasion and sprouting in response to 
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malignant breast and brain tumors [29,30] or behavior of breast cancer cells 
during the transition of ductal carcinoma in situ to invasive carcinoma [31].  
A device incorporating two stacked PDMS microchannel layers  
separated by a thin porous membrane was used to form heterotypic 
multicellular spheroids in a 3D microfluidic culture system [32,33] that 
recapitulates the tumor micro- environment of metastatic prostate cancer 
cells [34]. A similar strategy permitted study of intravascular adhesion of 
circulating metastatic breast cancer cells in response to endothelial 
activation under physiological flow conditions [35]. Using this model, 
basal stimulation of the endothelium with the cytokine, CXCL12, was 
shown to significantly increase adhesion of circulating breast cancer cells. 
Importantly, microengineering also can be used to mimic the complex 
biochemical microenvironment of living organs. A microfluidic perfusion 
bioreactor was constructed to impose oxygen gradients on hepatocytes co- 
cultured with fibroblasts to mimic physiological variations in hepatocyte 
form and function along the liver sinusoids, known as liver zonation, which 
is thought to depend on regional variations in oxygenation [36]. This 
microdevice effectively reconstituted the regional heterogeneity of liver 
microarchitecture as well as drug-induced zonal hepatotoxicity seen in 
vivo. A 3D microfluidic device was used to study chemotactic migration of 
malignant cancer cells under conditions in which cancer cells were 
precisely positioned relative to ‘source’ and ‘sink’ cells, which pro- duce 
and scavenge chemokines causing production of shal- lower and more 
physiological chemokine gradients [37].  
More recently, mechanically active microfluidic culture devices have 
been created that reproduce the dynamic physical forces that are crucial for 
organ function, as well as for disease development. For example, primary 
human small airway epithelial cells were cultured in a microfluidic channel 
and integrated with a computer-controlled, two-phase (air–liquid) 
microfluidic switching system to mimic the propagation and rupture of 
liquid plugs that occur during the reopening of collapsed airways that 
causes mechanical airway injury in obstructive pulmonary disease [38]. 
This study revealed severe injurious cellular responses to plug propagation 
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and rupture – and, impressively, these injury events could be detected 
acoustically in the device as crackling sounds nearly identical to the 
respiratory ‘crackles’ that physicians listen for through their stethoscopes 
to detect fluid in the lung.  
In a related study, a mechanically actuatable, multilayered, microfluidic 
device was developed to expose alveolar epithelial tissues to a combination 
of cyclic wall-stretch and repeated propagation of a moving air–liquid 
interface that reproduces the complex pathological mechanical forces 
experienced by alveolar epithelial cells during mechanical ventilation [39]. 
Quantitative analysis of mechanical cell injury in this ‘alveolus-on-a-chip’ 
revealed that a combination of solid and fluid mechanical stresses causes 
significantly more severe cell injury than either alone, supporting clinical 
observations that alveolar stretch alone is not sufficient to induce 
ventilator-induced lung injury. Thus, these relatively simple 
microengineered tissue mod- els offer an in vitro method to mimic some 
important facets of complex disease processes that depend crucially on 3D 
organ structure; again, this result could not be obtained using conventional 
3D gel cultures.  
 
 
Figure 1.8: The human-on-a-chip concept. Biomimetic microsystems 
representing different organs can be integrated into a single microdevice 
and linked by a microfluidic circulatory system. 
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1.4.	Tissue	Engineering	
 
The field of tissue engineering (regenerative medicine) aims to repair 
and regenerate damaged tissues by developing biological substitutes that 
mimic the natural extracellular matrix to help guide the growth of new 
functional tissue in vitro or in vivo to restore, maintain or improve tissue 
function. Tissue engineering technologies are based on a biological triad 
and involve the successful interaction between three components: (1) the 
scaffold that holds the cells together to create the tissue’s physical form, 
(2) the cells that synthesise the tissue and (3) signalling mechanisms (i.e. 
mechanical and chemical signals) that direct the cells to express the desired 
tissue phenotype [Vacanti, J. P., & Langer, R. (1999). Tissue engineering: 
the design and fabrication of living replacement devices for surgical 
reconstruction and transplantation. The lancet, 354, S32-S34.] 
		
Figure 1.9: Main steps of traditional tissue engineering paradigm. 
		 24	
Bioreactors can be used to provide the signals in this latter area in order 
to influence biological processes by the application of a mechanical 
stimulus, and may also be used as an alternative to, or in conjunction with 
growth factors.  
 
 
 
Fig. 1.10: The tissue engineering triad; factors that need to be considered 
when designing a suitable structure for tissue engineering applications 
(Lyons, et al., 2008). 
1.4.1.	Cells	
Tissue engineering utilizes living cells as engineering materials. 
Examples include using living fibroblasts in skin replacement or repair, 
cartilage repaired with living chondrocytes, or other types of cells used in 
other ways. 
From fluid tissues such as blood, cells are extracted by bulk methods, 
usually centrifugation or apheresis. From solid tissues, extraction is more 
difficult. Usually the tissue is minced, and then digested with the enzymes 
trypsin or collagenase to remove the extracellular matrix (ECM) that holds 
the cells. After that, the cells are free floating, and extracted using 
centrifugation or apheresis. Digestion with trypsin is very dependent on 
temperature: higher temperatures digest the matrix faster, but create more 
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damage. Collagenase is less temperature dependent, and damages fewer 
cells, but takes longer and is a more expensive reagent. 
Cells are often categorized by their source: autologous cells are obtained 
from the same individual to which they will be reimplanted. Autologous 
cells have the fewest problems with rejection and pathogen transmission, 
however in some cases might not be available. For example, in genetic 
disease suitable autologous cells are not available. Also very ill or elderly 
persons, as well as patients suffering from severe burns, may not have 
sufficient quantities of autologous cells to establish useful cell lines. 
Moreover, since this category of cells needs to be harvested from the 
patient, there are also some concerns related to the necessity of performing 
such surgical operations that might lead to donor site infection or chronic 
pain. Autologous cells also must be cultured from samples before they can 
be used: this takes time, so autologous solutions may not be very quick.  
Allogeneic cells come from the body of a donor of the same species. 
While there are some ethical constraints to the use of human cells for in 
vitro studies, the employment of dermal fibroblasts from human foreskin 
has been demonstrated to be immunologically safe and thus a viable choice 
for tissue engineering of skin. 
Xenogenic cells are these isolated from individuals of another species. In 
particular animal cells have been used quite extensively in experiments 
aimed at the construction of cardiovascular implants. 
Another distinction is between primary cells (derived from an organism) 
and cell line (taken from a cell bank). 
 Cell line or cell strain may be finite or continuous depending upon 
whether it has limited culture life span or it is immortal in culture. On the 
basis of the life span of culture, the cell lines are categorized into two 
types: 
 
1. Finite cell lines: the cell lines which have a limited life span and 
go through a limited number of cell generations (usually 20-80 
population doublings) are known as finite cell lines. These cell 
lines exhibit the property of contact inhibition, density limitation 
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and anchorage dependence. The growth rate is slow and doubling 
time is around 24-96 hours; 
2. Continuous cell lines: cell lines transformed under laboratory 
conditions or in vitro culture conditions give rise to continuous 
cell lines. These cell lines show the property 
of ploidy (aneupliody or heteroploidy), absence of contact 
inhibition and anchorage dependence. They grow either in a 
monolayer or in suspension. The growth rate is rapid 
and doubling time can be 12-24 hours.  
 
1.4.2.	Scaffolds	
    Scaffolds are materials that have been engineered to cause desirable 
cellular interactions to contribute to the formation of new functional tissues 
for medical purposes. Cells are often 'seeded' into these structures capable 
of supporting three-dimensional tissue formation. Scaffolds mimic the 
extracellular matrix of the native tissue, recapitulating the in vivo milieu 
and allowing cells to influence their own microenvironments. They usually 
serve for at least one of the following purposes: allow cell attachment and 
migration, deliver and retain cells and biochemical factors, enable diffusion 
of vital cell nutrients and expressed products, exert certain mechanical and 
biological influences to modify the behaviour of the cell phase. 
 To achieve the goal of tissue reconstruction, scaffolds must meet 
some specific requirements. A high porosity and an adequate pore size are 
necessary to facilitate cell seeding and diffusion throughout the whole 
structure of both cells and nutrients. Biodegradability is often an essential 
factor since scaffolds should preferably be absorbed by the surrounding 
tissues without the necessity of a surgical removal. The rate at which 
degradation occurs has to coincide as much as possible with the rate of 
tissue formation: this means that while cells are fabricating their own 
natural matrix structure around themselves, the scaffold is able to provide 
structural integrity within the body and eventually it will break down 
leaving the newly formed tissue which will take over the mechanical load. 
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Injectability is also important for clinical uses. Recent research on organ 
printing is showing how crucial a good control of the 3D environment is to 
ensure reproducibility of experiments and offer better results. 
 
1.4.2.1. Materials 
Many different materials (natural and synthetic, biodegradable and 
permanent) have been investigated. Most of these materials have been 
known in the medical field before the advent of tissue engineering as a 
research topic, being already employed as bioresorbable sutures. Examples 
of these materials are collagen and some polyesters. 
New biomaterials have been engineered to have ideal properties and 
functional customization: injectability, synthetic manufacture, 
biocompatibility, non-immunogenicity, transparency, nano-scale fibers, 
low concentration, resorption rates, etc. 
A commonly used synthetic material is PLA - polylactic acid. This is a 
polyester which degrades within the human body to form lactic acid, a 
naturally occurring chemical which is easily removed from the body. 
Similar materials are polyglycolic acid (PGA) and polycaprolactone (PCL): 
their degradation mechanism is similar to that of PLA, but they exhibit 
respectively a faster and a slower rate of degradation compared to PLA. 
While these materials have well maintained mechanical strength and 
structural integrity, they exhibit a hydrophobic nature. This hydrophobicity 
inhibits their biocompatibility, which makes them less effective for in vivo 
use as tissue scaffolding. In order to fix the lack of biocompatibility, much 
research has been done to combine these hydrophobic materials with 
hydrophilic and more biocompatible hydrogels. While these hydrogels have 
a superior biocompatibility, they lack the structural integrity of PLA, PCL, 
and PGA. By combining the two different types of materials, researchers 
are trying to create a synergistic relationship that produces a more 
biocompatible tissue scaffolding. 
Scaffolds may also be constructed from natural materials: in particular 
different derivatives of the extracellular matrix have been studied to 
evaluate their ability to support cell growth. Proteic materials, such as 
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collagen or fibrin, and polysaccharidic materials, like chitosan[23] or 
glycosaminoglycans (GAGs), have all proved suitable in terms of cell 
compatibility, but some issues with potential immunogenicity still remains. 
Among GAGs hyaluronic acid, possibly in combination with cross linking 
agents (e.g. glutaraldehyde, water-soluble carbodiimide, etc.), is one of the 
possible choices as scaffold material. Functionalized groups of scaffolds 
may be useful in the delivery of small molecules (drugs) to specific tissues. 
Another form of scaffold under investigation is decellularised tissue 
extracts whereby the remaining cellular remnants/extracellular matrices act 
as the scaffold. Recently a range of nanocomposites biomaterials are 
fabricated by incorporating nanomaterials within polymeric matrix to 
engineer bioactive scaffolds. 
 
1.4.2.2. Synthesis 
A number of different methods have been described in literature for 
preparing porous structures to be employed as tissue engineering scaffolds. 
Each of these techniques presents its own advantages, but none are free of 
drawbacks. 
 
Nanofiber self-assembly 
Molecular self-assembly is one of the few methods for creating 
biomaterials with properties similar in scale and chemistry to that of the 
natural in vivo extracellular matrix (ECM), a crucial step toward tissue 
engineering of complex tissues. Moreover, these hydrogel scaffolds have 
shown superiority in in vivo toxicology and biocompatibility compared to 
traditional macroscaffolds and animal-derived materials. 
 
Textile technologies 
These techniques include all the approaches that have been successfully 
employed for the preparation of non-woven meshes of different polymers. 
In particular, non-woven polyglycolide structures have been tested for 
tissue engineering applications: such fibrous structures have been found 
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useful to grow different types of cells. The principal drawbacks are related 
to the difficulties in obtaining high porosity and regular pore size. 
 
Solvent casting and particulate leaching 
Solvent casting and particulate leaching (SCPL) allows for the 
preparation of structures with regular porosity, but with limited thickness. 
First, the polymer is dissolved into a suitable organic solvent (e.g. 
polylactic acid could be dissolved into dichloromethane), then the solution 
is cast into a mold filled with porogen particles. Such porogen can be an 
inorganic salt like sodium chloride, crystals of saccharose, gelatin spheres 
or paraffin spheres. The size of the porogen particles will affect the size of 
the scaffold pores, while the polymer to porogen ratio is directly correlated 
to the amount of porosity of the final structure. After the polymer solution 
has been cast the solvent is allowed to fully evaporate, then the composite 
structure in the mold is immersed in a bath of a liquid suitable for 
dissolving the porogen: water in the case of sodium chloride, saccharose 
and gelatin or an aliphatic solvent like hexane for use with paraffin. Once 
the porogen has been fully dissolved, a porous structure is obtained. Other 
than the small thickness range that can be obtained, another drawback of 
SCPL lies in its use of organic solvents which must be fully removed to 
avoid any possible damage to the cells seeded on the scaffold. 
 
 
Fig. 1.11: Solvent casting and particulate leaching method for the 
fabrication of 3D porous scaffolds. 
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Gas foaming 
To overcome the need to use organic solvents and solid porogens, a 
technique using gas as a porogen has been developed. First, disc-shaped 
structures made of the desired polymer are prepared by means of 
compression molding using a heated mold. The discs are then placed in a 
chamber where they are exposed to high pressure CO2 for several days. 
The pressure inside the chamber is gradually restored to atmospheric levels. 
During this procedure the pores are formed by the carbon dioxide 
molecules that abandon the polymer, resulting in a sponge-like structure. 
The main problems resulting from such a technique are caused by the 
excessive heat used during compression molding (which prohibits the 
incorporation of any temperature labile material into the polymer matrix) 
and by the fact that the pores do not form an interconnected structure. 
 
Emulsification freeze-drying 
This technique does not require the use of a solid porogen like SCPL. 
First, a synthetic polymer is dissolved into a suitable solvent (e.g. 
polylactic acid in dichloromethane) then water is added to the polymeric 
solution and the two liquids are mixed in order to obtain an emulsion. 
Before the two phases can separate, the emulsion is cast into a mold and 
quickly frozen by means of immersion into liquid nitrogen. The frozen 
emulsion is subsequently freeze-dried to remove the dispersed water and 
the solvent, thus leaving a solidified, porous polymeric structure. While 
emulsification and freeze-drying allow for a faster preparation when 
compared to SCPL (since it does not require a time consuming leaching 
step), it still requires the use of solvents. Moreover, pore size is relatively 
small and porosity is often irregular. Freeze-drying by itself is also a 
commonly employed technique for the fabrication of scaffolds. In 
particular, it is used to prepare collagen sponges: collagen is dissolved into 
acidic solutions of acetic acid or hydrochloric acid that are cast into a mold, 
frozen with liquid nitrogen and then lyophilized. 
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Thermally induced phase separation 
Similar to the previous technique, the TIPS phase separation procedure 
requires the use of a solvent with a low melting point that is easy to 
sublime. For example, dioxane could be used to dissolve polylactic acid, 
then phase separation is induced through the addition of a small quantity of 
water: a polymer-rich and a polymer-poor phase are formed. Following 
cooling below the solvent melting point and some days of vacuum-drying 
to sublime the solvent, a porous scaffold is obtained. Liquid-liquid phase 
separation presents the same drawbacks of emulsification/freeze-drying. 
 
Electrospinning 
Electrospinning is a highly versatile technique that can be used to 
produce continuous fibers from submicrometer to nanometer diameters. In 
a typical electrospinning set-up, a solution is fed through a spinneret and a 
high voltage is applied to the tip. The buildup of electrostatic repulsion 
within the charged solution, causes it to eject a thin fibrous stream. A 
mounted collector plate or rod with an opposite or grounded charge draws 
in the continuous fibers, which arrive to form a highly porous network. The 
primary advantages of this technique are its simplicity and ease of 
variation. At a laboratory level, a typical electrospinning set-up only 
requires a high voltage power supply (up to 30 kV), a syringe, a flat tip 
needle and a conducting collector. For these reasons, electrospinning has 
become a common method of scaffold manufacture in many labs. By 
modifying variables such as the distance to collector, magnitude of applied 
voltage, or solution flow rate—researchers can dramatically change the 
overall scaffold architecture. 
Historically, research on electrospun fibrous scaffolds dates back to at 
least the late 1980s when Simon showed that electrospinning could be used 
to produced nano- and submicron-scale fibrous scaffolds from polymer 
solutions specifically intended for use as in vitro cell and tissue substrates. 
This early use of electrospun lattices for cell culture and tissue engineering 
showed that various cell types would adhere to and proliferate upon 
polycarbonate fibers. It was noted that as opposed to the flattened 
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morphology typically seen in 2D culture, cells grown on the electrospun 
fibers exhibited a more rounded 3-dimensional morphology generally 
observed of tissues in vivo. 
 
 
Fig. 1.12: Electrospinning technology for the fabrication of porous 
scaffolds. 
 
CAD/CAM technologies 
Because most of the above techniques are limited when it comes to the 
control of porosity and pore size, computer assisted design and 
manufacturing techniques have been introduced to tissue engineering. First, 
a three-dimensional structure is designed using CAD software. The 
porosity can be tailored using algorithms within the software [40]. The 
scaffold is then realized by using ink-jet printing of polymer powders or 
through Fused Deposition Modeling of a polymer melt. 
A 2011 study by El-Ayoubi et al. investigated "3D-plotting technique to 
produce (biocompatible and biodegradable) poly-L-Lactide macroporous 
scaffolds with two different pore sizes" via solid free-form fabrication 
(SSF) with computer-aided-design (CAD), to explore therapeutic articular 
cartilage replacement as an "alternative to conventional tissue repair" [41]. 
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The study found the smaller the pore size paired with mechanical stress in a 
bioreactor (to induce in vivo-like conditions), the higher the cell viability in 
potential therapeutic functionality via decreasing recovery time and 
increasing transplant effectiveness [42]. 
 
 
Fig. 1.13: CAD technology for the fabrication of 3D porous scaffolds with 
defined morphology. 
   Laser-assisted bioprinting  
   In a 2012 study, Koch et al. focused on whether Laser-assisted 
BioPrinting (LaBP) can be used to build multicellular 3D patterns in 
natural matrix, and whether the generated constructs are functioning and 
forming tissue. LaBP arranges small volumes of living cell suspensions 
in set high-resolution patterns. The investigation was successful, the 
researchers foresee that "generated tissue constructs might be used for in 
vivo testing by implanting them into animal models" [43]. As of this 
study, only human skin tissue has been synthesized, though researchers 
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project that "by integrating further cell types (e.g. melanocytes, 
Schwann cells, hair follicle cells) into the printed cell construct, the 
behavior of these cells in a 3D in vitro microenvironment similar to their 
natural one can be analyzed", useful for drug discovery and toxicology 
studies. 
 
   Assembly methods 
   One of the continuing, persistent problems with tissue engineering is 
mass transport limitations. Engineered tissues generally lack an initial 
blood supply, thus making it difficult for any implanted cells to obtain 
sufficient oxygen and nutrients to survive, or function properly. 
 
   Self-assembly 
   Self-assembly may play an important role here, both from the 
perspective of encapsulating cells and proteins, as well as creating 
scaffolds on the right physical scale for engineered tissue constructs and 
cellular ingrowth. The micromasonry is a prime technology to get cells 
grown in a lab to assemble into three-dimensional shapes. To break 
down tissue into single-cell building blocks, researchers have to dissolve 
the extracellular mortar that normally binds them together. But once that 
glue is removed, it's quite difficult to get cells to reassemble into the 
complex structures that make up our natural tissues. While cells aren't 
easily stackable, building blocks are. So the micromasonry starts with 
the encapsulation of living cells in polymer cubes. From there, the 
blocks self-assemble in any shape using templates. 
 
   Additive manufacturing 
   It might be possible to print organs, or possibly entire organisms using 
additive manufacturing techniques. A recent innovative method of 
construction uses an ink-jet mechanism to print precise layers of cells in 
a matrix of thermoreversible gel. Endothelial cells, the cells that line 
blood vessels, have been printed in a set of stacked rings. When 
incubated, these fused into a tube. 
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The field of three-dimensional and highly accurate models of biological 
systems is pioneered by multiple projects and technologies including a 
rapid method for creating tissues and even whole organs involves a 3D 
printer that can print the scaffolding and cells layer by layer into a 
working tissue sample or organ.  
 
1.4.3.	Bioreactors	
     A bioreactor in tissue engineering is a device that attempts to simulate a 
physiological environment in order to promote cell or tissue growth in 
vitro. A physiological environment can consist of many different 
parameters such as temperature and oxygen or carbon dioxide 
concentration, but can extend to all kinds of biological, chemical or 
mechanical stimuli. Therefore, there are systems that may include the 
application of forces or stresses to the tissue or even of electric current in 
two- or three-dimensional setups. 
In academic and industry research facilities, it is typical for bioreactors to 
be developed to replicate the specific physiological environment of the 
tissue being grown (e.g., flex and fluid shearing for heart tissue growth). 
Several general-use and application-specific bioreactors are also 
commercially available, and may provide static chemical stimulation or 
combination of chemical and mechanical stimulation. 
There are a variety of bioreactors designed for 3D cell cultures. There 
are small plastic cylindrical chambers, as well as glass chambers, with 
regulated internal humidity and moisture specifically engineered for the 
purpose of growing cells in three dimensions. The bioreactor uses bioactive 
synthetic materials such as polyethylene terephthalate membranes to 
surround the spheroid cells in an environment that maintains high levels of 
nutrients. They are easy to open and close, so that cell scaffolds can be 
removed for testing, yet the chamber is able to maintain 100% humidity 
throughout. This humidity is important to achieve maximum cell growth 
and function. The bioreactor chamber is part of a larger device that rotates 
to ensure equal cell growth in each direction across three dimensions. 
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Fig. 1.14: Different interactions between cells and scaffolds if cultured in 
static or in dynamic (within bioreactor) conditions. 
 
Main types of bioreactors are: spinner flask bioreactors, rotating wall 
bioreactors, compression bioreactors, flow perfusion bioreactors. 
 
Spinner flask bioreactors 
Spinner flask bioreactors are maybe the simplest and the most frequently 
used bioreactor types. Spinner bioreactor types mix the oxygen and 
nutrients throughout the medium and reduce the concentration boundary 
layer at the construct surface. In a spinner flask, scaffolds are suspended at 
the end of needles in a flask of culture media. A magnetic stirrer mixes the 
media and the scaffolds are fixed in place with respect to the moveing 
fluid. Flow across the surface of the scaffolds results in turbulences and 
flow instabilities caused by clumps of fluid particles that have a rotational 
structure superimposed on the mean linear motion of the fluid particles. Via 
these added fluid motions fluid transport to the centre of the scaffold is 
thought to be enhanced. Typically, spinner flasks are around 120 ml in 
		 37	
volume (although much larger flasks of up to 8 liters have also been used). 
The most frequent stirring speed is 50–80 rpm and generally 50% of the 
total medium is changed every two days. The efficiency of the 
enhancement of mass transport is indicated that cartilage constructs have 
been grown in spinner flasks to thicknesses of 0.5 mm compared to that of 
100 mm in static cultures. However, cell seeding efficiency is typically low 
in spinner flask bioreactors, this method usually fails to deliver 
homogeneous cell distribution throughout scaffolds and cells 
predominantly reside on the construct periphery. 
 
 
Fig. 1.15: Spinner flask bioreactor. 
 
    Rotating wall bioreactors 
The rotating wall bioreactor was originally developed by NASA. It was 
designed with a view to protect cell culture experiments from high forces 
during space shuttle take off and landing. The device has proved useful in 
tissue engineering laboratories on Earth too. In a rotating wall bioreactor, 
scaffolds are free to move in media in a vessel. A rotating wall vessel 
bioreactor consists of a cylindrical chamber in which the outer wall, inner 
wall, or both are capable of rotating at a constant angular speed. The vessel 
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wall is then rotated at a speed such that a balance is reached between the 
downward gravitational force and the upward hydrodynamic drag force acting 
on each scaffold. The wall of the vessel rotates, providing an upward 
hydrodynamic drag force that balances with the downward gravitational force, 
resulting in the scaffold remaining suspended in the media. Dynamic laminar 
flow generated by a rotating fluid environment is an alternative and efficient 
way to reduce diffusional limitations of nutrients and wastes while producing 
low levels of shear compared to the stirring flask. Culture medium can be 
exchanged by stopping the rotation temporarily or by adding a fluid pump 
whereby media is constantly pumped through the vessel. Fluid transport is 
enhanced in a similar fashion to the mechanism in spinner flasks and the 
rotational devices also provide a more homogeneous cell distribution 
compared to static or spinner bioreactor cultures. Gas exchange occurs 
through a gas exchange membrane. Typically, the bioreactor is rotated at 
speeds of 15–30 rpm. Cartilage tissue of 5 mm thickness has been grown in 
this type of bioreactor after seven months of culture. As tissue mass increases 
while cells grow in the bioreactor, the rotational speed must be increased in 
order to balance the gravitational force and to ensure that the scaffold remains 
in suspension. 
 
 
Fig. 1.16: Rotating wall bioreactor. 
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    Compression bioreactors 
Compression bioreactors are another widely used type of bioreactors. This 
class of bioreactor is generally used in cartilage engineering and can be 
designed so that both static and dynamic loading can be applied. In general, 
compression bioreactors consist of a motor, a system providing linear motion 
and a controlling mechanism to provide different magnitudes and frequencies. 
A signal generator can be used to control the system including loading of cells 
while transformers can be used to measure the load response and imposed 
displacement. The load can be transferred to the cell-seeded constructs via flat 
platens which distribute the load evenly. However, in a device for stimulating 
multiple scaffolds simultaneously, care must be taken that the constructs are of 
similar height or the compressive strain applied will vary as the scaffold height 
does. Mass transfer is improved in dynamic compression bioreactors over 
static culture (as compression causes fluid flow in the scaffold) which results 
in the improvement of the aggregate modulus of the resulting cartilage tissue 
to levels approaching those of native articular cartilage. 
 
 
Fig. 1.17: Compressing bioreactor. 
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 Perfusion bioreactors 
Culture using flow perfusion bioreactors has been shown to provide more 
homogeneous cell distribution throughout scaffolds. 
In comparisons between flow perfusion, spinner flask and rotating wall 
bioreactors, flow perfusion bioreactors have proved to be the best for fluid 
transport. Using the same flow rate and the same scaffold type, while cell 
densities remained the same using all three bioreactors, the distribution of the 
cells changed dramatically depending on which bioreactor was used. 
Histological analysis showed that spinner flask and static culture resulted in 
the majority of viable cells being on the periphery of the scaffold. In contrast, 
the rotating wall vessel and flow perfusion bioreactor culture resulted in 
uniform cell distribution throughout the scaffolds. Flow perfusion bioreactors 
generally consist of a pump and a scaffold chamber joined together by tubing. 
A fluid pump is used to force media flow through the cell-seeded scaffold. The 
scaffold is placed in a chamber that is designed to direct flow through the 
interior of the scaffold. The scaffold is kept in position across the flow path of 
the device and media is perfused through the scaffold, thus enhancing fluid 
transport. Media can easily be replaced in the media reservoir. However, the 
effects of direct perfusion can be highly dependent on the medium flow rate. 
Therefore optimising a perfusion bioreactor for the engineering of a 3D tissue 
must address the careful balance between the mass transfer of nutrients and 
waste products to and from cells, the retention of newly synthesised ECM 
components within the construct and the fluid induced shear stresses within 
the scaffold pores. 
 
 
Fig. 1.18: Perfusion bioreactor. 
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1.5.	Cancer	Tissue	Engineering	
As previously seen, tissue engineering (TE) has evoked new hopes for 
the cure of organ failure and tissue loss by creating functional substitutes in 
the laboratory. Besides various innovations in the context of Regenerative 
Medicine (RM), TE also provides new technology platforms to study 
mechanisms of angiogenesis and tumour cell growth as well as potentially 
tumour cell spreading in cancer research. Such TE-Cancer research models 
allow us to investigate the interactions that occur when replicating 
physiological and pathological conditions during the initial phases of 
replication, morphogenesis, differentiation and growth under variable given 
conditions. Tissue microenvironment has been extensively studied in many 
areas of TE and it plays a crucial role in cell signalling and regulation of 
normal and malignant cell functions.  
The synthesis of TE with innovative methods of molecular biology and 
stem-cell technology may help investigate and potentially modulate 
principal phenomena of tumour growth and spreading, as well as tumour-
related angiogenesis.  
The concept of cancer tissue engineering is very recent, but holds great 
promise. In 2006, at the dawn of cancer tissue engineering studies, the TE 
community pointed out their next generation guidelines, underlining the 
necessity of complex biomimetic models, nicely correlating stem cell 
differentiation on TE scaffolds with developmental biology. To achieve the 
formation of mature functional substitutes ex vivo, tissue engineers, were 
thus suggested to focus on the regeneration of metastable 
microenvironments, where complex cell-cell and cell-extracellular matrix 
(ECM) interactions can develop in a biomimetic fashion. Such guidelines 
actually also retrace the features that an optimal tumour modelling should 
have. In this view, cancer development biology can meet the TE approach 
with a renewed emphasis. These new platforms can be exploited to learn 
about fundamental cell-biomaterial interactions and cell-cell 
communications, being valid for both normal and cancer cells. When cell 
populations are used to form tissues and organs, proper 3D systems, with 
		 42	
clinically relevant dimensions, are required to eventually scale up these 
findings into effective new treatments. 
 
 
 
Figure 1.10. Integration of cancer biology and tissue engineering 
competences, at the base of the cancer tissue engineering concept. 
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Chapter	2	
3 Thesis	objectives	
The aim of this thesis is the study, development and validation of new in 
vitro 3D tumor models through the use of bioengineering and tissue 
engineering approaches. Among all solid tumours, we focused our attention 
on breast cancer, the most common cancer in women. 
 
• The study on a new model of low aggressive breast cancer has the 
aim to provide a realistic model of 3D primary breast tumour. In this 
work, I used mechanically tuned alginate hydrogels to study the role 
of substrate elasticity on breast adenocarcinoma cell activity. I 
observed a strict correlation between cell viability and substrate 
elasticity; in particular, the highest cellular proliferation rate, 
associated with the formation of typical cell clusters, occurred in 
two weeks only in the softest hydrogels (E = 150–200 kPa). 
 
• Considering the importance of breast cancer metastasis, the study on a 
new model of highly aggressive breast cancer has the aim to provide a 
3D in vitro model able to allow cells to show some key features related 
to their motility and aggressive potential. To this aim, we developed 
composite gels constituted by different concentrations of Alginate (A) 
and Matrigel (M) to obtain a structurally stable-in-time and 
biologically active substrate. Human aggressive breast cancer cells (i.e. 
MDA-MB-231) were cultured within the gels. A particular type of gel 
(i.e. 50% Alginate, 50% Matrigel) emerged thanks to a series of 
significant results: cells exhibited peculiar cytoskeleton shapes and 
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poly-nuclei organization characteristic of their malignancy; cells 
expressed the formation of the so-called invadopodia, actin-based 
protrusion of the plasma membrane through which cells anchor to the 
extracellular matrix; cells were able to migrate through the gels and 
attach to an engineered membrane mimicking the vascular walls hosted 
within bioreactor. 
   
• Finally, a full set-up was developed to observe in vitro cell detachment 
from a primary tumor model and entering in circulation. We combined 
a bioreactor-based bioengineering approach with single cell analysis of 
Circulating Tumor Cells (CTCs). Analysis of human CTCs has now 
revealed important features of cancer metastasis, such as the high 
metastatic potential of CTC-clusters compared to single CTCs. For this 
reason, we applied the same approach to our in vitro system. Single 
cell qPCR of the circulating LM2 cells was performed. A proof-of-
concept that the approach can work was performed, as well as evidence 
that the cells can be extracted from the device and used for molecular 
analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 48	
Chapter	3	
4 3D	in	vitro	model	of	low	aggressive	
breast	cancer	
3.1.	 Abstract	
Three-dimensional (3D) cell cultures represent fundamental tools for the 
comprehension of cellular phenomena both in normal and in pathological 
conditions. In particular, mechanical and chemical stimuli play a relevant 
role on cell fate, cancer onset and malignant evolution. In this work, I used 
mechanically-tuned alginate hydrogels to study the role of substrate 
elasticity on breast adenocarcinoma cell activity. The hydrogel elastic 
modulus (E) was measured via atomic force microscopy (AFM) and a 
remarkable range (150–4000 kPa) was obtained. A breast cancer cell line, 
MCF-7, was seeded within the 3D gels, on standard Petri and alginate-
coated dishes (2D controls). Cells showed dramatic morphological 
differences when cultured in 3D versus 2D, exhibiting a flat shape in both 
2D conditions, while maintaining a circular, spheroid-organized (cluster) 
conformation within the gels, similar to those in vivo. Moreover, we 
observed a strict correlation between cell viability and substrate elasticity; 
in particular, the number of MCF-7 cells decreased constantly with 
increasing hydrogel elasticity. Remarkably, the highest cellular 
proliferation rate, associated with the formation of cell clusters, occurred 
at two weeks only in the softest hydrogels (E = 150–200 kPa), highlighting 
the need to adopt more realistic and a priori defined models for in vitro 
cancer studies. 
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3.2	 Materials	and	methods	
3.2.1.	3D	alginate	gel	preparation	
     Three-dimensional alginate gels were prepared as follows. Firstly, 1% 
(w/v) agar solutions containing calcium ions (solutions A) were prepared 
by mixing Agar (DIFCO Laboratories) in physiological buffer enriched 
with different concentrations (0.2 M, 0.5 M or 1 M) of CaCl2 (J. T. Baker). 
The solutions were brought to the boil, poured into 6-well plates until 1 cm 
height was obtained and allowed to cool until complete solidification. 
Holes of 0.5 cm diameter were then cut in the agar, using a Pasteur glass 
pipette, to make gel molds. Alginate solutions, 0.5% (w/v), 1% (w/v) or 2% 
(w/v), were prepared by mixing Alginate (Manugel GMB, FMC 
BioPolymer) in physiological buffer (solutions B). Effective intimate 
mixing of the alginate solutions was carried out for 12 h at room 
temperature under vigorous magnetic stirring. The solutions were then 
stored at 4 °C. Next, 120 μl of each solution B was dispensed into the 
selected gel molds using a syringe. Gelation was allowed to take place at 
37 °C for 1 hour, in order to ensure complete diffusion of calcium ions 
from the agar to the alginate solution. The alginate hydrogels were then 
extracted from the gel molds and maintained in a buffer containing 5 mM 
CaCl2. 
 
3.2.2	Atomic	Force	Microscopy	(AFM)	nanoindention	
    Atomic force microscopy (AFM) was used to measure gel stiffness. To 
do this, we used a commercial AFM microscope (Keysight Technologies 
5500 ILM) equipped with a closed loop scanner capable of 9µm vertical 
range. The scanner was always operated in “closed loop” in order to 
compensate for piezo nonlinearity, creep and hysteresis. A rectangular, 250 
µm long, silicon microcantilever with sharp conical tips and a cone angle 
of 22°  was used (CSG 11 type, NT-MDT, Russia). The cantilever spring 
constant was calculated by monitoring the cantilever oscillation in air due 
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to thermal noise, following the procedure described by Hutter and 
Bechhoefer [1]. 
Gels were glued onto a Petri dish using a minimum amount of fast 
cyanoacrylate glue. During the gluing step, the specimens stayed less than a 
minute out of the solution [2]. During measurement, samples were kept in a 
buffer containing 5 mM CaCl2.  
AFM indentation measurements were performed by recording a standard 
force curve and then calculating the corresponding load versus indentation 
curve.  
The applied load for any given cantilever deflection was calculated by first 
converting the output voltage, from the AFM four-segment photodetector, 
into nanometers of deflection (sometime referred to as “inverse optical 
lever sensitivity”), and then by multiplying the deflection by the cantilever 
spring constant. The conversion factor was calculated by taking several 
force curves on a hard glass substrate, every time the laser spot on the 
cantilever had to be adjusted, and considering the reciprocal of the average 
slope of the constant compliance region of the curves.  
In order to take into account intra-sample heterogeneity, 16×16 =256  force curves were recorded over a regular grid over a 5×5 mm2 area. 
Each force curve was taken at a constant vertical displacement speed of 6 
mm/s and with a maximum applied load that varied from sample to sample 
in order to get a maximum sample deformation (i.e. indentation) of 100 nm.  
Single force curves were processed in a semi-automatic way using a 
custom built software in order to i) detect the vertical displacement 
corresponding to the AFM probe-gel surface contact (during this procedure 
10% of the curves on average were discarded due to noise or artefacts 
during acquisition which prevented the detection of the point of contact), ii) 
extract the applied load P as a function of the sample indentation h (the so-
called load-indentation curve). 
In order to calculate the Young’s modulus of the gel we considered the 
unloading portion of the load-indentation curve to avoid effects due to 
plastic deformations and referred to the model for a quasi-static indentation 
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with a conical indenter originally proposed by Oliver and Pharr [3] and 
then refined by the same authors [4]: 
 E = 221− ν2SA 
 
where: ν is the Poisson’s ratio of the hydrogel               A is the projected indenter contact area at a given indentation               S  the contact stiffness, defined as the derivative of the load-
 indentation curve at the same indentation. 
 
We calculated, for all measurements, contact area and stiffness at the 
maximum indentation h!"# = 100 nm. Applying the same model, in order 
to calculate the derivative at h!"#, we fitted the load-indentation relation 
with a power law: P = a ∙ hm where a and m are the fitting parameters (m 
lays in the range 1.5-2 for a conical indenter [4]).  
We assumed, for the Poisson’s ratio of all tested gels, a constant value of ν = 0.5, corresponding to an uncompressible, rubber like, material. 
On a single gel sample, at least three maps of 16×16 curves over grouped 
collected onto macroscopically different positions randomly selected over 
the sample surface. Hence the reported elasticity value for each gel type 
corresponds to the average of at least 690 single measurements and 
evaluations of the Young’s modulus. 
Statistical evaluation was performed using the non-parametric Mann-
Whitney test to determine significant differences among groups. The 
significance level was set at p<0.05. All results are presented as mean ± 
standard deviation. 
It should be noted that the indentation measurements were not performed in 
quasi-static conditions and therefore the viscous response (loss modulus) 
might play a significant role; moreover the calculated absolute values of 
elasticity are prone to several uncertainties and non-idealities (e.g. in the 
tip geometry or the gel Poisson’s ratio). Nevertheless, since all AFM 
measurements reported in this paper were taken with the same cantilever 
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and the same experimental conditions, the observed relative changes in 
stiffness are not significantly affected by the above uncertainties. 
  
									3.2.3			MCF-7	cell	culture	
					The MCF-7 (breast adenocarcinoma) cell line was obtained from Sigma 
Aldrich. Cells were expanded in Eagle's minimal essential medium 
(EMEM) enriched with 10% Fetal Bovine Serum (FBS), 1% L-glutamine 
and 1% penicillin/streptomycin (all from Sigma Aldrich). When the 
required confluence was reached, cells were detached with 1X trypsin and 
counted. Cell seeding within the gels was achieved by directly suspending 
cells in sterile alginate solution in order to obtain an inoculum of 105 
cells/sample. Culture medium enriched with 5 mM CaCl2 was then added. 
Two-dimensional cell cultures were carried out as a control to evaluate 
whether differences occurred on cells when cultured in 2D or 3D 
conditions. To this aim, MCF-7 cells were seeded at 3500 cells/cm2 density 
on both standard plastic and alginate-coated Petri dishes. 
Both 2D and 3D cell cultures were incubated for up to 2 weeks at 37° C in 
an atmosphere of 5% CO2 to allow gas exchange. Medium was changed 
twice a week. At least duplicate samples were used for each assessment. 
	
3.2.4			Live/Dead	staining	
After 7 days, cellular viability was analyzed in the 3D gels. For this 
purpose, gels were washed with phosphate-buffered saline (PBS) and 
incubated with a Live/Dead stain (Live/Dead Cell Double Staining Kit, 
Sigma Aldrich) at 37° C for 15 minutes. 
Gels were then imaged by using an upright microscope equipped with 
transmitted illumination and epifluorescence (Eclipse Ni-U, Nikon)20 to 
discriminate live cells (calcein AM stained-green) from dead cells 
(propidium iodide stained-red).  
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	3.2.5			Flow	cytometry		
 After 1 week, at least three gels per type were de-cross-linked by 
incubating them for 2 hours with a 1:1 (v/v) solution of 50 mM EDTA and 
complete medium. Cells were suspended in PBS enriched with 2% FBS 
(v/v) and stained for 5 minutes by incubating in Propidium Iodide (PI) 
solution (1% v/v). Flow cytometry was performed on a FACS Calibur 
system to obtain total and dead cell (PI-stained) counts. 
 
3.2.6.	 Confocal	 fluorescence	 microscopy	 and	 morphological	
analysis	
To examine the spatial distribution and morphology of cells, both 2D 
and 3D samples were analysed by optical confocal laser-scanning 
microscopy. For all typologies, samples were fixed, after 1 week, with 4% 
paraformaldehyde and treated with 0.1% Triton X-100 to permeabilize the 
cell membrane. Nuclei were stained with 1 μg/ml 4,6-Diamidino-2-
phenylindole (DAPI), while actin filaments were stained with 100 μM 
Alexa Fluor 488 Phalloidin (all Sigma-Aldrich). Images were acquired by a 
confocal laser-scanning microscope (Leica TCS SP5 AOBS). Alexa Fluor 
488 was excited with the 488 nm line of the Ar laser and its fluorescence 
was collected in a spectral window of 500 to 530 nm. For DAPI, 720 nm 
excitation wavelength and 450-500 nm spectral window emission were 
used. 
Images were then analysed by ImageJ to measure and quantify several 
morphological features characterizing cells grown both in 3D and in 2D 
conditions. In particular, the following parameters were considered: Area 
of the cell; Perimeter of the cell; Major Axis and Minor Axis of the best 
fitting ellipse; Circularity, defined as 4πArea/Perimeter^2; Roundness, 
defined as Minor Axis/Major Axis. 
 
	 					3.2.7			Histology	and	cluster	analysis	
     After 1 and 2 weeks of culture, the 3D alginate hydrogels were 
processed for histological analysis in order to observe the time-dependent 
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evolution of cell clusters. Briefly, samples were fixed in 4% buffered 
formalin for 3 hours and dehydrated in ethanol scale for a total of 6 hours. 
The samples were then paraffin embedded, cross-sectioned (7-µm thick) at 
different levels and stained with haematoxylin–eosin (H&E)21,22. Images 
were acquired by using a Nikon H550L optical microscope. 
We evaluated two parameters of cell clusters: dimension and density. 
For dimension analysis, at least 10 clusters (intended as group of 
communicating cells) were considered for each hydrogel, and the major 
axis of each cluster (i.e. cluster size) was measured. These values were 
subdivided into ranges (i.e. <10 mm, 10-30 mm, 30-50 mm, 100-150 mm, 
150-200 mm, 200-250 mm, >250 mm) and clusters classified; results are 
presented as percentage of occurrence (Figure 6). 
Cluster density, defined as: 
 D = cells areawithin a clustercluster area %  
 
was quantified. To this aim, images of clusters were post-processed by 
using Image J platform: they were converted to 8-bit images and an 
automatic threshold was applied to discriminate the space occupied by cells 
(black) from the background (white). Threshold accuracy was checked 
manually for each image. Cluster density was calculated, in percentage, as 
ratio between black space and the total area of the cluster. 
 
3.3.	 Results	
 
 3.3.1.	3D	alginate	gel	realization 
     The adopted protocol produced 3D alginate gels, chemically cross-
linked via radial diffusion of calcium ions (Figure 1, panels A, B). 
Structural differences among gels produced with different cross-linker 
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molarities and alginate concentrations were clearly observable: in detail, 
gels with 2% alginate solution and cross-linked with 0,5 M CaCl2 appeared 
structurally more compact and three-dimensionally defined than gels 
produced with either a lower concentration of alginate or a lower CaCl2 
molarity (data not shown). In accordance with the dimensions of the gel 
molds, we obtained circular alginate gels, with ∼5 mm diameter and ∼3 mm 
height (Figure 1, panel C). 
 
 
Figure 3.1: Gel manufacturing process. The protocol adopted for 
realization of the alginate gel consists of several steps, as summarized in the 
following picture: realization of the agar gel enriched with Calcium ions; 
realization of the gel molds, in the agar plates, using a Pasteur glass pipette; 
introduction of the alginate solution into the gel molds and alginate 
gelation. Panel A is a cartoon of these steps, while panel B shows some 
pictures of the experimental realization. Panel C shows two types of 
alginate gel samples prepared with 0.5% w/v (left) and 2% w/v (right) 
alginate solution and cross-linked with 0.5 M CaCl2 (scale bar: cm). 
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				3.3.2.		Gel	mechanical	characterization	by	AFM	
    The elastic modulus of each gel was measured at the sub-micrometer 
scale, the same length scale of the actual cell sensing23, using AFM 
nanoindentation technique. 
Figure 2 (panels A-B) shows, as an example, three representative 
indentation measurements for gels with 1 M CaCl2 and different alginate 
concentrations. The average force map (256 curves taken on a 5x5 µm! area) of both the raw force-distance curves (panel A) and the 
corresponding load-indentation curves (panel B) are displayed. The latter 
were used to calculate the Young’s modulus of the gel. The curves show a 
qualitative, yet evident, difference in the compliance of the different gels 
while deformed by the AFM tip. Figure 2, panel C, reports the mean values 
and their dispersion of the Young’s modulus measured over the gel surface 
by AFM nanoindentation, following the procedure described in the 
methods section. As evidenced, a weaker cross-linker content (i.e. 0.2 M 
CaCl2) did not allow significantly different stiffnesses to be obtained 
among the gels, despite the increase in alginate percentage. On the 
contrary, the elastic moduli were significantly different at 0.5-1-2% 
alginate concentrations when gels were cross-linked with higher CaCl2 
content (i.e. 0.5 M and 1 M). Gels with overlapping ranges of stiffness (i.e. 
0.5% alginate-0.5 M CaCl2 with 0.5% alginate-1 M CaCl2 and 2% 
alginate-0.5 M CaCl2 with 1% alginate-1 M CaCl2) were merged as a 
unique range, to finally obtain four different categories of stiffness in 
which the gels were subdivided (i.e. 150-200 kPa; 300-350 kPa; 900-1800 
kPa; 2500-4000 kPa). 
Our results demonstrate that gel stiffness is highly dependent on CaCl2 
cross-linker concentration. Table 1 reports some values from the 
literature24-26 on alginate gel elastic modulus, measured by AFM 
nanoindentation. Although CaCl2 concentrations do not overlap with our 
samples, the trend of increasing stiffness with an increase in both alginate 
and CaCl2 concentrations is in agreement with our observations. 
 
		 57	
 
 
Figure 3.2: Gel mechanical characterization. Gel stiffness was measured by 
Atomic Force Microscopy. Panel A shows three representative force versus 
vertical displacement curves (average of 256 curves, full approachretraction 
cycle is plotted) measured on three different gels (0.5% w/v, 1% w/v and 
2% w/v alginate, all crosslinked with 1 M CaCl2). The z = 0 corresponds to 
the vertical piezo displacement where the AFM tip gets into contact with 
the gel surface. Panel B shows the plots of the corresponding load versus 
indentation curves; only the unloading portions are plotted. Panel C shows 
the elastic modulus (average and standard deviation, STD) for the different 
gels probed by AFM nanoindentation: bar colours correspond to different 
alginate concentrations, while calcium molarity is shown along the x axis. 
Symbol *indicates samples with statistically different elasticity (Mann-
Whitney test, p < 0.05). Symbol Åòindicates gels with elasticity ranges that 
are overlapped. 
3.3.3.		Cell	viability	
     Cell viability in the alginate gels was evaluated after 7 days of culture 
using both the Live/Dead cell assay and FACS analysis. In detail, we used 
a fluorescence-based Live/Dead assay to acquire qualitative information on 
cell vitality, while FACS analysis was used to obtain a semi-quantitative 
outcome on cell number within each gel type. From the images in Figure 3, 
panel A, it is observable that only a few dead cells were found in gels after 
7 days, confirming alginate as a promising substrate for cell culture and 
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validating the adopted gelation protocol. However, a deep discrepancy in 
cell colonization among different gel types was evident.  
For FACS analysis, MCF-7s were firstly characterized (Figure 3, panels B 
and C) to set the best operational conditions; the number of live and dead 
cells was then derived for each gel type in relation to substrate stiffness 
(Figure D). FACS analysis confirmed and highlighted the differences in 
cell viability of the various gel types; in particular, the detected amount of 
cells is higher in gels characterized by a lower elastic modulus. The number 
of live cells seems to be influenced by substrate stiffness, while the number 
of dead cells (determined by propidium Iodide staining) is independent of 
substrate stiffness.  
 
3.3.4.		Cell	morphology:	2D	versus	3D	
   Cell morphology and organization in 3D gels were analysed by 
observing cytoskeleton orientation and cell-to-cell contact using a confocal 
microscope. As the control, MCF-7 cells, seeded on both standard and 
alginate-coated Petri dishes, were observed. 
As expected27,28, the morphological observation after one week of culture 
showed alarming morphological differences between cells in 2D and 3D. In 
particular, cells showed a flat morphology and were organized in a 
monolayer when seeded in standard or alginate-coated Petri dishes (Figure 
4, panels A and B). In contrast, cells embedded within 3D gels were 
characterized by a round shape and cluster organization (Figure 4, panel C). 
Several cell colonies were observed, and multiple nuclei were present in 
each colony meaning that each cluster consisted of many cells. These 
differences are of great impact considering that changes in morphology 
often go hand-in-hand with biochemical changes, as demonstrated by other 
scientists: in 2007, Kenny et al. not only showed that strong differences 
occurred in breast cancer cells when cultured in 2D or 3D, but classified 
several breast cancer cell lines with different aggressiveness, as proven by 
gene expression analysis, into four distinct morphological groups: Round, 
Mass, Grape-like and Stellate. In that study, MCF-7 cells belonged to the 
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Mass group, since they formed colonies with disorganized nuclei and filled 
colony centres29.  
Going beyond the current state-of-the-art, we measured the changes in 
MCF-7 morphological features when cultured in different dimensional 
configurations (2D or 3D). Our results show that cells in 3D are 
characterized by a greater Area and Perimeter than in 2D, and by a greater 
balance between Major and Minor Axes. Consequently, they show higher 
values of Roundness than cells in 2D, characterized by elongated shapes. 
Circularity values are not statistically different among the different 
conditions (Figure 4, panel D). 
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Figure 3.3: Cell viability. Representative images of live (green) and dead 
(red) MCF-7 cells encapsulated in alginate hydrogels with different alginate 
and CaCl2 concentrations, after 7 days of culture; images were acquired by 
fluorescence microscopy after treating samples with a Live/Dead assay; 
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gels are co-labelled with their stiffness (panel A). Flow cytometric analysis 
of MCF-7 cells after 7 days of 3D culture in alginate gels. Viability of cells 
was analysed by setting a gate based on the Side- (SSC) and Forward- 
(FSC) light SCatter (panel B), and measuring the percentage of PI positive 
staining cells within the gate, indicating dead cells (panel C). Number of 
live and dead cells per sample type (samples with different stiffness), after 
7 days, estimated by FACS analysis (panel D). Error bar represents 
Standard Deviation (STD). 
 
Figure 3.4: Cell morphology. Cells cultured on plastic (panel A), alginate-
functionalized plastic (panel B) or embedded in 3D alginate hydrogels 
(panel C) show strongly different morphologies (blue: DAPI; green: 
Phalloidin). In particular, cells exhibit a flat shape in both 2D conditions; 
this morphology, even though selfexplanatory of a good cell adhesion, 
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heavily limits cell-to-cell contacts, which are maintained in 3D culture. 
Panel D shows quantitative information about cell morphologies in relation 
to their culture environment; in detail: area, perimeter, major axis, minor 
axis, circularity and roundness were analyzed for each culture condition. 
All the measures are expressed in μ m, except Roundness and Circularity, 
which are dimensionless (values ranging from 0 to 1). 
	
3.3.5.		Cell	cluster	formation	
The presence of cell clusters was investigated in 3D gels by histological 
analysis of the gel inlets. For this analysis, only gels which had given the 
best cell viability results (i.e. 150-200 kPa, 300-350 kPa and 900-1800 kPa 
stiffness) were analysed. Initially, cells were distributed evenly as single 
cells inside each type of gel (data not shown). After 7 days, most of the 
cells within the hydrogels with low stiffness (150-200 kPa) proliferated to 
form spheroids with a mean size of 100 mm (Figure 5, panel A). In 
contrast, in stiffer gels, only a few cells composed the majority of clusters 
(Figure 5, panels B and C). After 14 days, the size of aggregates in cell 
laden gels with low stiffness increased to 300 µm (Figure 5, panel C); the 
cluster size remained almost constant in stiffer substrates (>300 kPa), 
where cells did not show similar proliferation ability (Figure 5, panels D 
and E).	
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Figure 3.5: Cell proliferation and cluster formation. Histology of three 
alginate types (150–200 kPa, 300–350 kPa and 900–1800 kPa). 
Hematoxylin/eosin-stained sections are shown at 7 (left column) and 14 
days (right column). Alginate (alg) is identified by the pink background, 
while cells (cel) are indicated by arrows and are purple. It is clearly 
observable that, if in stiff substrates cells are relatively isolated without 
significant proliferation rates both at 7 and 14 days (panels C, E and D, F, 
respectively), in soft gels they are highly proliferate, reaching clusters of 
100 μm in one week (panel A) and 300 μm in two weeks (panel B). 
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The presence of clusters in relation to their dimensions was analysed for 
each type of gel. Results are shown in Figure 6. It can be observed that in 
moderately stiff (900-1800 kPa) and medium stiffness gels (300-350 kPa), 
clusters maintained small dimensions (<10 mm and about 30 mm, 
respectively) after both 1 and 2 weeks of culture. In contrast, in the softest 
gels (150-200 kPa), clusters reached greater dimensions (200 mm and > 
250 mm after 1 and 2 weeks of culture, respectively), and the percentage of 
isolated cells decreased. 
In soft cell laden alginates, together with a higher cluster dimension, we 
also observed higher values of cluster density, which passed from 56% 
(±3,6%) during the first week to 70% (±6,5%) in the second week (Table 
2). 
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Chapter	4	
5 3D	in	vitro	model	of	highly	aggressive	
breast	cancer	
4.1.	Abstract	
Purpose of this study was the development of a 3D material to be used as 
substrate for breast cancer cell culture. We developed composite gels 
constituted by different concentrations of Alginate (A) and Matrigel (M) to 
obtain a structurally stable-in-time and biologically active substrate. Human 
aggressive breast cancer cells (i.e. MDA-MB-231) were cultured within the 
gels. Known the link between cell morphology and malignancy, cells were 
morphologically characterized and their invasiveness correlated through an 
innovative bioreactor-based invasion assay. 
A particular type of gel (i.e. 50% Alginate, 50% Matrigel) emerged thanks to a 
series of significant results: 
1. cells exhibited peculiar cytoskeleton shapes and poly-nuclei organization 
characteristic of their malignancy; 
2. for the first time in a 3D in vitro environment, cells expressed the formation 
of the so-called invadopodia, actin-based protrusion of the plasma membrane 
through which cells anchor to the extracellular matrix; 
3. cells were able to migrate through the gels and attach to an engineered 
membrane mimicking the vascular walls hosted within bioreactor, providing a 
revolutionary 3D in vitro model of the very precursor steps of metastasis.   
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4.2.	Materials	and	methods	
 
4.2.1.	Cell	culture	
Commercially available human MDA-MB-231 cells were used. MDA-MB-
231 is an adherent cell line derived from pleural effusion of primary breast 
adenocarcinoma. 
Cells were cultured in DMEM medium supplemented with 10% Fetal Bovine 
Serum (FBS) and 1% penicillin-streptomycin (P/S) (all from Sigma Aldrich), 
hereafter referred to as complete medium. Same cells were used both for 3D 
and 2D controls. 
 
4.2.2.	Tumour	hydrogel	preparation	and	culture	
To prepare alginate solution, alginate powder (Manugel GMB, FMC 
BioPolymer) was mixed in physiological buffer at a concentration of 0.5% 
(w/v), as previously assessed 30. Effective intimate mixing was guaranteed by 
exposing alginate solution for 12 hours under vigorous magnetic stirring at 
room temperature. Matrigel was thawed over night at 4 °C. Meanwhile, an 
agar solution at 1% (w/v) concentration was prepared by mixing Agar (DIFCO 
Laboratories) in physiological buffer enriched with 0.5 M of CaCl2 (J. T. 
Baker). The solution was brought to the boil, poured into 6-well plates until ~1 
cm height was obtained and allowed to cool until complete solidification. 
Holes of 0.5 cm diameter were then cut into the agar, using a Pasteur glass 
pipette, to make molds. 
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Cells were enzymatically detached from tissue plates and suspended in 
alginate solution. The suspension was moved to ice and Matrigel was added in 
variable quantity depending on the composite. Initially, we tested the 
following combinations: (i) 100% alginate (hereafter 100% A); (ii) 75% 
alginate and 25% Matrigel (hereafter 75%:25% A:M); 50% alginate and 50% 
Matrigel (hereafter 50%:50% A:M); 25% alginate and 75% Matrigel 
(hereafter 25%:75% A:M); 100% Matrigel (hereafter 100% M). The final cell 
density was 1 million/ml for all gel types. 
To form a single gel, 100 µl of solution containing 100.000 cells were 
dispensed into agar molds using a tip. Gelation was allowed to take place at 37 
°C for 1 hour and 15 minutes, in order to ensure the complete diffusion of 
calcium ions from agar to alginate solution and the thermally induced cross-
linking of Matrigel. 
Gels were gently removed from the molds, transferred into a 96 multi-well 
plate and maintained in complete medium containing 5 mM CaCl2. Medium 
was changed every two days. A schematic representation of the protocol is 
shown in Figure 1, panel A. 
 
4.2.3.	Cell	viability	assay	
After 24 hours, cellular response to gel interaction was investigated to 
prove the biocompatibility of the new composites. For this purpose, gels were 
washed with phosphate-buffered saline (PBS) and incubated with a Live/Dead 
staining (Live/Dead Cell Double Staining Kit, Sigma Aldrich) at 37 °C for 15 
minutes. Gels were then imaged using an upright microscope equipped with 
transmitted illumination and epifluorescence (Eclipse Ni-U, Nikon) to 
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discriminate live cells (calcein AM stained-green) from dead cells (propidium 
iodide stained-red). 
 
4.2.4.	Histology 
After 7 days, cell-laden hydrogels were processed for histological analysis 
in order to observe the level of intimate mixing of alginate and Matrigel in 
generating new composites and the distribution of cells within. Briefly, 
samples were dehydrated in ethanol scale, paraffin embedded, cross-sectioned 
(7 μm thick) at different levels and stained with Masson trichrome. Images 
were acquired by using a Nikon H550L optical microscope. 
 
4.2.5.	Confocal	microscopy 
To examine the morphology of cells within the gels, 3D samples were 
analysed by optical confocal laser-scanning microscopy. 2D plastic cultures 
and paraffin-embedded xenograft slices were used as controls. 
3D gels were fixed with 4% paraformaldehyde after 1, 4 and 7 days. 
Nuclei were stained with 1 g/ml propidium iodide (PI), while actin 
filaments were stained with 100 µM Alexa Fluor 488 Phalloidin (both by 
Sigma-Aldrich). Before PI staining, gels were treated with 100 µg/ml Rnase 
for 30 minutes. 
Images were acquired through a confocal laser-scanning microscope (Leica 
TCS SP5 AOBS) with a sequential image acquisition to avoid spectral cross-
talk. Alexa Fluor 488 was excited with the 488 nm line of the Ar laser and its 
fluorescence was collected in a spectral window of 500 to 580 nm. For PI, 543 
nm excitation wavelength and 600–700 nm spectral window emission were 
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used. For 3D gels, stacks comprising 100 optical sections, each with a 
375×375-µm field of view and 512×512-pixel image matrix, were obtained 
through a depth of 100 µm.  
Xenograft paraffin-embedded sections derived from orthotopic xenografts of 
MDA-MB-231 cells in mice were provided by the National Cancer Research 
Institute of Genoa (Italy). Shortly, Swiss nu/nu immunocompromised mice 
were purchased from Charles River (Calco, Como) and maintained in 12-hour 
dark/light cycles with water and food ad libitum. Animals were housed and 
maintained in the Animal Care Facility of the IRCCS San Martino-IST, 
accordingly to national and European regulations (D.L. 4/3/14 No. 26; 
86/609/EEC Directive). All animal experiments were approved by the internal 
Ethic Committee and by the Italian Ministry of Health. A group of 27 six-
week-old female mice were anesthetized with a mixture of Ketamine-Xylazine 
given intraperitoneally, the mammary fat pad of the inguinal fourth gland was 
exposed and 500.000 cells were injected in 10 l of PBS using a disposable 
syringe with a 29 G needle. Animals were monitored daily and euthanized 
when tumors reached the size of 1200 mm3 and before any sign of suffering 
became detectable. Tumors were removed and frozen for genomic analysis 31. 
Sections of 50 µm were cut rehydrated, and stained with PI and Alexa Fluor 
488 Phalloidin. 
 
4.2.6.	Image	post-processing	
In order to aid visualization of the arrangement of nuclei and actin 
filaments, the registered images were processed using the public domain NIH 
ImageJ program. Signals due to nuclei or actin filaments were separated from 
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that due to background on the basis of signal intensity and grey-scale 
morphology. The same program was used to obtain 3D rebuilding of gels by z-
stack methodology. 
 
4.2.7.	Nuclei	segmentation	and	quantification	
Cell proliferation rate within 3D materials was obtained by counting the 
number of nuclei within the reconstructed confocal stacks. To do that, we 
adopted a protocol of nuclei segmentation developed by other authors 32, that 
combines the Lines-of-Sight (LoS) concept with a local adaptive pre-
processing to separate apparently touching cell nuclei into approximately 
convex parts representing single cell nuclei. Numbers of nuclei at days 4 and 7 
were finally normalized on nuclei at day 1, in order to be presented as 
proliferation rates. The procedure of nuclei segmentation is schematically 
represented in Figure 3, panel B. 
 
4.2.8.	Size	and	shape	cell	analysis	
Confocal images were analysed by ImageJ to measure and quantify several 
features characterizing cells growing in 3D conditions. In particular, we 
considered cell area, perimeter, major axis and minor axis lengths. 
We finally defined two parameters to evaluate the grade of irregularity and 
elongation of cell cytoskeleton: 
 
!"#$ !"#$%& (!!)  =  !"#$!"#$%"&"#!                             (1) 
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!"#$%&'(#$ !"#$% (!")  =  !"#$% !"#$!"#$% !"#$                                (2) 
For a perfect circle (cell with round shape) the FF value tends to !!!. 
 
4.2.9.	 Electrospinning	 of	 polycaprolactone	 membranes	 and	
scanning	electron	microscopy	(SEM)	
Electrospun membranes were produced by dissolving polycaprolactone 
(PCL) in 1:1 absolute ethanol:chloroform (Bio-Optica) to create a 20% (w/v) 
final solution. The polymer solution was loaded into a syringe (12 ml), and a 
21 Gauge needle was attached. The syringe was securely fitted to a syringe 
pump-driver (Harvard Apparatus PHD 2000). The needle tip was connected to 
a high voltage power source (Gamma High Voltage ES50P-10W) operating at 
7 kV 33 and positioned 12 cm from the collection plate (covered with an 
aluminium foil) 34. The PCL solution was delivered at a constant flow rate of 2 
ml/hour for 4 h. Finally, the membranes were air-dried for 24 h to allow 
residual solvent to evaporate. 
The microstructure and porosity of PCL membranes were evaluated with a 
scanning electron microscope (SEM Hitachi 2500) after metallization with 
gold by using a Polaron SEM coating system.  
 
4.2.10.	 Assembly	 of	 tumour	 hydrogel	 and	 membrane	 within	
bioreactor	for	recapitulating	the	metastatic	condition	
The set-up for cell intravasation was assessed by using the multi-organ 
bioreactor by React4life S.r.l. (www.react4life.com). The peculiarity of this 
system is the possibility to host 3D engineered tissues strictly in contact with a 
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porous membrane, eventually functionalized to better mimic the blood vessel 
environment. 
The previously described electrospun membranes were sterilized by irradiating 
with ultraviolet (UV) light at a distance of 10 cm over night; after that, they 
were sterilely placed between two polycarbonate rings to define the useful 
experimental area, pre-conditioned by pipetting 1% w/v gelatine solution in 
PBS above and incubated for 15 minutes. Finally, gelatine coating was 
removed and membranes were washed in PBS. 
One membrane per experiment was placed within the multi-organ bioreactor. 
The tumour hydrogel was placed in the upper part of the bioreactor in contact 
with the membrane, to allow cells escaped from the gel to functionally attach 
to the membrane and to eventually enter in the bottom part of bioreactor, that 
is connected to a fluidic circuit enabling their collection. 
The cellular migration and intravasation was monitored by confocal sectioning 
on the membrane after 3 days.  
 
4.3.	 Results	
 
4.3.1.	Composite	hydrogel	assessment	
     Hydrogel initial compositions (i.e. 100% A, 75%:25% A:M, 50%:50% 
A:M, 25%:75% A:M, 100% M) were firstly assessed from a structural point of 
view. Hydrogels belonging to 25%:75% A:M and 100% M categories did not 
show a proper robustness and structural stability and thus were immediately 
excluded (Figure 1, panel B). The other three categories were chosen as 
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substrates for 3D cell culture. Initially, gels of 100 μl were loaded with 
200.000 cells each one; however, this concentration caused a fast degradation 
of the 50%:50% A:M category (Figure 1, panel C). To our knowledge of the 
current literature, this behaviour may be caused by the action of the metal-
protease MT-MMP, necessary for cell proliferation and for the integrin-
mediated invasion process. To solve these issues, already expressed in some 
works in literature 35, we adopted two different strategies: first, cell density 
was reduced from 200.000 to 100.000 per gel, ensuring a still good cell-to-cell 
contact. Secondly, we functionalized the bottom of the culture plate with a thin 
layer of Matrigel before moving gels into, as suggested by Lee et al. 36. 
Under these conditions, stable gels for the whole experimental period were 
obtained (Figure 1, panel D).  
 
 
Figure 4.1: Composite cell-laden gel development. a) Schematic 
description of the protocol used to produce 3D cell-laden Alginate-
Matrigelcomposite gels: breast cancer cells MDA-MB-231 are seeded first 
in liquid alginate and then Matrigel is added working on ice. The cell-laden 
solution is transferred into Agar molds enriched with CaCl2 ions at 37 °C 
for to allow gelation. Then, 3D gels are removed by molds and trasferred 
into plates with culture media. b) Gels composed by 25%:75% A:M and 
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100% M ratios resulted too soft and not handy. c) a concentration of 2 
million cells/ml caused a fast degradation of 50%:50% A:M gels, thus it 
was reduced to 1 million cells/ml. d) finally, structurally compact gels were 
obtained. 
Immunohistological staining (trichrome) and imaging of MDA-MB-231 cells 
embedded within the three different composite materials highlight the good 
intimate mixing of Matrigel and Alginate (the color of substrates tends to 
green increasing Matrigel content, as shown in Figure 2). 
 
 
Figure 4.2: Histological analysis. - Immunohistological staining 
(trichrome) and imaging of MDA-MB-231 cells (black) embedded within 
the three different composite materials. The color of substrates tends to 
green increasing Matrigel content. 
 
4.3.2.	High	viability	and	cell	proliferation	within	gels	
     Tumor cells in the hydrogels demonstrated high viability and density 
(Figure 3, panel A) also in the inner parts of materials and time-dependent 
growth consistent with observations from confocal images (Figure 3, panel C), 
validating our gelation protocol and gel mass transport properties. Although 
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initial cellular proliferation in gels on day 4 was marginally low, it recovered 
to above 4 fold change relative to the initial cell number on day 7. 
 
 
Figure 4.3: Cell viability and proliferation. a) MDA-MB-231 cells cultured 
with materials for 24 h, stained with fuorescence dyes: calceinAM (green) for 
live cells and propidium iodide (red) for dead cells. b) procedure for nuclei 
segmentation to count cell number within different materials at different time 
points c) MDAMB- 231 cell proliferation obtained by nuclei segmentation 
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after4 and 7 days of culture for different materials. Symbol * indicates 
statistical significance (t-test, P<0.05). 
 
 
4.3.3.	 Cell	morphology:	 polinuclei,	 invadopodia,	 cytoskeleton	
irregularity	and	elongation 
Cell morphology was firstly qualitatively assessed. Both in 2D and in vivo 
(xenograft) conditions, MDA-MB-231 cells expressed, as expected, their 
typical elongated and stellate morphology (Figure 4, panels A and B). 
Trying to obtain a similar conformation also in a 3D environment, we 
analyzed cell morphology within the three different categories of gels at three 
different time points (1, 4 and 7 days). 
In alginate gels, cells maintained a round morphology, typical of suspension 
phase and expressive of a non-malignancy condition, regardless of time point 
(Figure 4, panels C, D, E); in presence of Matrigel, cells tended to elongate, 
accordingly to their aggressiveness (Figure 4, panels F to K). More 
interestingly and in contrast to 2D controls, in the same gels we observed a 
poly-nuclei conformation, known to be linked to malignancy as well. Indeed, 
while nuclei assumed a round and regular shape in 100% A gels (Figure 4, 
panel L), they showed a multiple and jagged conformation in presence of 
Matrigel (Figure 4, panels M and N). Finally, only in 50%:50% A:M gels, we 
observed manifestation of invadopodia (Figure 4, panels I to K), actin-based 
protrusion of the plasma membrane through which cancer cells anchor to the 
Extracellular Matrix and degrade it. This feature, never observed in a 3D in 
vitro environment, was expressed by MDA-MB-231 in the same gels 
regardless of time point.  
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Figure 4.4: Cell morphological characterization. a) Morphology of MDA-
MB-231 breast cells cultured in two-dimensions. Cells were stained for F-
actin (phalloidin) and nuclei were counterstained with DAPI; cells show a 
stellate morphology. b) Confocal section of representative xenograft implant 
of MDA-MB-231. Cells were stained for F-actin (phalloidin) and nuclei were 
counterstained with Propidium Iodide. Cells show elongated/stellate 
morphology. c)-k) Confocal sections of representative cells embedded within 
Alginate/Matrigel composite gels at different time points (1, 4 and 7 days). 
Cells were stained for F-actin (phalloidin) and nuclei were counterstained with 
Propidium Iodide. Cells show round morphology in 100% A gels, thus not 
expressing their spreading capability; they show elongated morphology in 
75%:25% A:M gels; they finally show stellate morphology and invadopodia 
(red arrows) in 50%:50% A:M gels. l-n) Nuclei shapes isolated from c-to-k 
panelsvshow that in presence of Matrigel cells express poly-nuclei 
conformation, characteristic of malignancy. 
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From a quantitative point of view, gels containing a Matrigel component 
showed morphological features closer to elongated cells cultured in 2D 
conditions (Figure 5, panel B). Irregularity (Figure 5, panel C) and elongation 
(Figure 5, panel D) resulted proportional to Matrigel content, highlighting that 
50%:50% A:M gels are the most permissive to cell arrangement and 
organization in a 3D environment. In detail, irregularity is inversely 
proportional to Form Factor, since a value of Form Factor closer to 
!!! means 
that cells exhibit a most regular shape. 
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Figure 4.5: Morphological parameters extrapolation. a) The extrapolation of 
cell morphological parameters follows different main steps. In the first step 
(top), images are adjusted through a series of transformation, i.e. grey-scale 
transformation and threshold. The area of the cell is then automatically 
selected, but a manual check is done by overlapping cytoskeleton (actin) 
image. Finally, parameters such as area, perimeter, major and minor axes are 
automatically extrapolated by the software. b) Area, Perimeter, Major Axis 
and Minor Axis (averages, standard deviation) of cells cultivated on 2D 
substrates and within the composite gels. Red lines mean statistical 
significance (t-test, P<0.05). c) Irregularity Factor (IF) for cells within the 
gels. Higher the IF, greater the irregularity of cell shape d) Elongation Index 
(EI) for cells within the gels. Higher the EI, greater the elongation of cell 
shape. 
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4.3.4.	Cell	motility	in	bioreactor	
After 3 days in culture, membranes were removed from bioreactor and 
analysed under microscope to observe the presence of entrapped cells. While 
we did not observe any cells in matrices corresponding to 100% A gels, our 
results show that both in 75%:25% A:M and in 50%:50% A:M cells were able 
to migrate through the gels, escape from them and adhere to the porous 
electrospun PCL-gelatine membranes (Figure 6, panels C to F), confirming 
these materials as permissive substrates for the study of 3D tumour cell 
invasion in vitro. 
 
 
Figure 4.6: Preliminary steps of metastasis in bioreactor.  a) Schematic 
representation of the set-up for observation of cell spread and intravasation. 
Bioreactor was developed by React4life S.r.l. b) Electrospun membrane 
used to mimick blood vessel interface. The membranes were realized in 
polycaprolacton (PCL) by electrospinning technique. c-f) Confocal slides of 
cell entrapped within the membrane (cell is in false colours). 
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Chapter	5	
6 A novel bioreactor combined 
with single cell analysis allows 
recapitulating preliminary steps 
of metastasis paradigm in vitro	
5.1.	Abstract	
Metastasis process plays a key role on the prognosis of breast cancer, but lots 
of aspects are still unanswered. 
 In this work, we combined a bioreactor-based bioengineering approach with 
single cell analysis of Circulating Tumor Cells (CTCs). Analysis of human 
CTCs has now revealed important features of cancer metastasis, such as the 
high metastatic potential of CTC-clusters compared to single CTCs. For this 
reason, we applied the same approach to our in vitro system. Single cell qPCR 
of the circulating LM2 cells was performed. A proof-of-concept that the 
approach can work was performed, as well as evidence that the cells can be 
extracted from the device and used for molecular analysis. 
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5.2.	Materials	and	Methods	
5.2.1.	Experimental	set-up	
MOOD (Multi-Organ On Device) bioreactor by React4life S.r.l. is composed 
by a main chamber, subdivided into two units by a membrane. The membrane 
is interchangeably, thus different membranes can be used according to the 
experiment. Three-way valves connecting Marprene oxygen-permeable tubes 
provide an easy replacement of the culture medium. The overall system is 
governed by a commercial peristaltic pump. The described set-up works into a 
standard humidified incubator at 37 °C and 5% CO2.  
To recreate two physically independent environments (i.e. the primary tumour 
environment and the metastatic one) we used two bioreactors set in series. Of 
the two bioreactors used, the first one hosted a 3D engineered breast tumour 
and a membrane allowing detached cells entering in circulation; the second 
one hosted a second membrane, allowing circulating cells to enter into the 
"metastatic chamber". The first chamber and the fluidic circuit were loaded 
with DMEM enriched with 1% FBS and 1% pen/strept, while the 
second/metastatic chamber was loaded with DMEM enriched with 10% FBS 
and 1% pen/strept, thus creating a serum gradient to improve cell motility.  
The fluid velocity was set to 0.7×10!!  !!   (capillary blood average speed). 
The cellular migration and intravasation was monitored by removing the 
medium every 24 hours and counting the circulating cells into the different 
circuits (main and metastatic).  
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Figure 5.1: Schematic representation of the whole experiment. Two MOOD 
bioreactors are set in series to recreate both the intravasation and the 
extravasation processes. In the first MOOD, a 3D cell-laden gel is hosted as 
primary tumour model, in contact with the first membrane, so that cells can 
detach from the gel and enter in circulaton. Every 24 hours, media is 
sampled and replaced both from the main and the metastatic chamber. Cell 
counting is performed, then some cells are picked and analyzed. 
 
5.2.2.	Membrane	development	
Electrospun polycaprolactone (PCL)-based membranes were produced to be 
adopted as interfaces (both between the primary tumour and the fluidic circuit, 
and the fluidic circuit and the metastatic chamber). PCL ensures mechanical 
robustness to the membrane besides good biocompatibility; electrospinning 
technique allows obtaining highly porous matrices with various pore sizes 
ranging, firstly allowing an easy nutrient transport, secondly resulting 
permissive to cell migration37. 
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To this aim, a custom-made electrospinning set-up was used. A solution of 
PCL (440744 by Sigma-Aldrich) at 20% w/v in chloroform/ethanol (1:1 v/v) 
mixture was realized and transferred to a 6 ml syringe connected to a 21 
Gauge blunt tipped needle, as suggested by other authors38. The tip-to-
collection plate (covered with aluminium foil) distance was 12 cm34. The 
needle tip was connected to a high voltage power source (Gamma High 
Voltage ES50P-10W) operating at 7 kV33, and the polymer solution was feed 
into the needle at a rate of 2 ml/h by a syringe pump (Harvard Apparatus PHD 
2000). The PCL membranes were detached and glued by a silicon-like glue to 
the inferior side of the disc in order to cover the hole and left in ventilate 
environment to dry over night. Membranes were detached after 5 hours of 
deposition and functionalized with a gelatin coating just prior to use. Gelatin-
coated membranes are known to promote cell attachment39, so this 
functionalization was adopted to attract escaping breast cancer cells from the 
primary tumour. The coating was realized on the top of the membrane by 
covering the PCL layer with 1% w/v gelatin (Gelatin from bovine skin, 
G9391, Sigma Aldrich) solution in phospate buffered saline (PBS). The 
solution was allowed to penetrate the PCL structure for 20 minutes at 37 °C; 
after this time, the exceeding gelatin was removed by a pipette. The described 
membranes were sterilized by irradiating with ultraviolet (UV) light at a 
distance of 10 cm over night; after that, they were placed in bioreactor. The 
tumour hydrogel was placed in the upper part of the bioreactor in contact with 
the membrane, to allow cells escaped from the gel to functionally attach to the 
membrane and to eventually enter in the bottom part of bioreactor, that is 
connected to a fluidic circuit enabling their collection. 
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5.2.3.	Scanning	electron	microscopy	(SEM)	
Membrane porosity and morphology were examined by scanning electron 
microscopy (SEM). To this aim, samples taken from membranes were gold 
and a Hitachi S2500 SEM was employed. Images were acquired at 3.90K 
magnification. 
 
5.2.4.	Cell	culture  
MDA-MB-231 LM2 (herein referred to as LM2) cells are a derivative of 
MDA-MB-231 cells (breast adenocarcinoma) selected for their ability to 
metastasize to lung tissue in vivo. LM2 were expanded in Dulbecco's modified 
Eagle's medium (DMEM) enriched with 10% Fetal Bovine Serum (FBS) and 
1% penicillin/streptomycin (all from Sigma Aldrich). When the required 
confluence was reached, cells were detached with 1X trypsin. 
 
5.2.5.	3D	breast	tumour	model		
As primary breast tumour model, we developed fibrin-based cell-leaden 
hydrogels, realized as follows. For a single gel of 100 ml, a solution of HEPES 
(17,7 ml) and fibrinogen (32,3 ml) was prepared (solution A). As cross-linking 
solution (solution B), we mixed a CaCl2-based buffer (20 ml) with 3 ml of 
thrombin and 1,5 ml of Factor XIII. Solution B was allowed to mix at 37 °C 
for 30 minutes, then 25,5 ml of HEPES were added (solution C). 1 million of 
LM2 cells were suspended in solution A (50 ml), then solution C (50 ml) was 
added. The resultant was speedily mixed and deposited on a silicone mold, 
then incubated for 15 minutes to allow gelification. 
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Gels were washed into PBS solution in order to remove superficial, already 
detached cells and then were put within the bioreactor (one gel per 
experiment), in contact with the membrane. 
 
5.2.6.	Live/dead	cell	analysis	and	microscopy	
Just after jellification, gels were incubated with a Live/Dead assay (Live/Dead 
Cell Double Staining Kit, Sigma Aldrich) at 37° C for 15 minutes to analyse 
cell viability and distribution. The 3D gel was imaged by using an upright 
microscope equipped with transmitted illumination and epifluorescence 
(Eclipse Ni-U, Nikon) to discriminate alive cells (calcein AM stained-green) 
from dead cells (propidium iodide stained-red).  
 
5.2.7.	Fluid	dynamic	model	
In order to identify the best working conditions within the bioreactor, a 
physical model of the dynamic forces acting on circulating cells was carried 
out. In particular, we evaluated if the imposition of the capillary blood average 
speed (0.7×10!!  !! ) within the bioreactor could allow cells to flow within the 
circuit without sedimenting. 
To do this, we considered a single cell immersed in a liquid having rheological 
properties similar to the medium culture. In this context, the forces acting on 
the cell are: the gravity force F!, the Archimedes force F! and the Stokes force F!, respectively defined as: 
1)                                                                 F! = m×g 
where m is the cell mass and g is the gravity acceleration; 
2)        F! = g×ρ×V 
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where g is the gravity acceleration, ρ is the fluid density and V is the cell 
volume; 
3)        F! = 6π×µ×r×v 
where µ is the fluid viscosity, r is the cell radium and v is the velocity of the 
cell within the fluid; v is the only variable of the three equations, and it can be 
imposed at the peristaltic pump level. 
By substituting the variables with their known values, we obtain: 
F! = 9.8 × 10!!"  ms!× kg =  9.8 × 10!!" N F! = 9.8 × 10! × 5.2 × 10!!"  ms!× kgm!× m! = 5.1 × 10!!" N F! = 6 × 3.14 × 10!! × 10!! × 0.7 × 10!! = 1.3 × 10!!! N 
By comparing the three values of the forces, we can see that the Stokes force 
is slowly predominant respect to the other forces. Consequently, cells 
circulating within the fluid and subjected to a capillary-like speed will tend to 
flow within the system rather than to deposit.  
 
5.2.8.	Cell	counting	and	picking	
After sampling from bioreactor, the material was transferred to low suspension 
6-well plates. The very limited amount of cell material involved in metastatic 
studies required the use of a single cell manipulator. Cell picking was 
performed through the use of a CellCelector robotic system (ALS, Automated 
Lab Solutions) for semi-automatic single cell micromanipulation. This 
consists of an inverted microscope combined with micropipettes movable 
through motorized mechanical stages. Micropipettes are made of ultrathin 
glass capillaries coupled to an aspiration unit. 
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Firstly, a scanning of the whole source plate was performed in order to detect, 
select and count the number of cells and to acquire single cell or clusters 
images. Then, via microscope observation, specific cell were selected and 
aspirated by applying suction to the capillary micropipette. The aspirated 
liquid volume including the selected cell was transferred to a collection tube, 
where it was released by dispensation, in RNA buffer and conserved at -80 °C.  
 
5.2.9.	RNA	analysis	
LM2 cells were transfected with siRNA and were treated 24 h later with or 
without TGF 1 or SB-431542 for an additional 24 h. Total RNA was purified 
using Quick-RNA MiniPrep kit, and cDNA synthesis was performed using 1 g 
RNA and iScript cDNA synthesis kit (Bio-Rad) according to manufacturer’s 
protocol. qPCR was performed using Fast SYBR Green enzyme (Applied 
Biosystems) and measured on ViiA 7 real time PCR system (Applied Biosys- 
tems). Transcript levels were analyzed using the Ct method. 
5.3.	Results	
5.3.1.	Membrane	characterization	
Fig. 2 shows images of membranes realized with a deposition of 5 hours. This 
deposition time allows obtaining membranes that are both structurally resistant 
and porous enough to allow cell migration into the thickness direction of the 
membrane.  
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Figure 5.2:	 A) SEM image of the electrospun membanes (scale bar: 6.2 mm). B) 
Optical microscopy image of the same membrane (brightfield; scale bar 10 mm). C) 
Optical fluorescence microscopy image of the same membrane (gelatine is auto-
fluorescent in red). D) Merge of panels B and C. 
 
5.3.2.	Engineered	breast	tumor	
The adopted protocol produced 3D fibrin-based gels (Fig. 5, panel A). The 
cell-laden gels were cultured in bioreactor up to 48 hours (Fig. 5, panel B). 
Fig. 5, panel C, show cell distribution within the gel by optical microscopy; as 
visible, cells are distributed along the whole area of the material, while they 
appear greater or smaller basing on their position along the gel height. Images 
of the gels stained with the Live/Dead reagent show that there were many 
live/viable cells and that cells uniformly covered the majority of the surface 
area of the gels. 
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Figure 5.3: A) Fibrin-based gels with embedded LM2 cells just after jellification. B) 
MOOD bioreactor with the gel inside the camber. C) Optical microscopy image 
(brightfieldI) of the cell-laden gel. D) Optical fluorescence microscopy image of the 
cell-laden gel, stained with Dead/Alive kit (green: live cells; red: dead cells). Scale 
bar: 100 mm. 
5.3.3.	Set-up	assessment	
The set-up, consisting of 2 MOOD bioreactors connected in series, oxygen-
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permeable Marprene tubes, three-way valves for sampling/replacement of 
culture medium, two electrospun membranes housed inside the bioreactor 
chambers and an engineered fibrin-based artificial tumour, was placed in an 
incubator at controlled temperature and humidity for 2 days. The set-up has 
been connected to the peristaltic pump for the whole duration of the 
experiment in order to maintain the capillary velocity of the fluid inside. 
 
5.3.4.	Cell	picking	
Cell passage from the gel (primary tumor) to the fluidic circuit, and from this 
to the metastatic chamber, was monitored by removing and replacing the 
medium every 24 hours for a total of 2 days. As early as the first 24 hours, 
both single and cluster cells were detected both in the primary and in the 
metastatic circuit, confirming that they are able to migrate through the porosity 
of the membranes (Fig. 4, panels A and B). Some cells were aspirated by 
applying suction to the capillary micropipette; the CellCelector software 
documents each cell picking process by taking an image from the picking area 
before, during and after picking the cell (Fig. 4, panels C to E).  
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Figure 5.4: A) Single LM2 observed in circulation after 24 hours. B) Cluster of two 
LM2 cells observed in circulation after 24 hours. C-D-E) Sequence of cell picking 
process: a single cell (red circle) is aspirated by the glass capillary of CellCelector. 
 
5.3.5.	Cell	counting	
Number of intravasated/extravasated cells (cells passed into the main and the 
metastatic circuit, respectively) was monitored up to 48 hours and converted to 
percentage respect to the initial amount of cells. Figure 5, panel A shows that 
an average of 0.1% was found in the main circuit after one day, while 0.01% 
was found at the same time into the metastatic chamber. After 48 hours from 
the beginning of the experiment, quantities increased to 0.51% and 0.1% into 
the main and metastatic circuits, respectively. 
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Figure 5.5: - A) Counting of CTCs found in the main and metastatic circuits after 
24 hours and 48 hours. Counting is expressed as percentage of the number of cells 
seeded within the gel. B) Expression of GAPDH, Vimentin and EGFR (all three well 
established markers of LM2) and CD45 (negative control, white blood cell marker) of 
a circulating LM2. 
 
We know from literature that a tumor reaching the size of 1 cm3 
(approximately 1 g wet weight) is commonly assumed to  contain 1 x 109 
cells. However, mostly in  epithelial tumors (such as breast cancer), a cell 
number one order of magnitude smaller (108 cells) would be more realistic40. 
We also know that circulating tumor cells (CTCs) are a fundamental 
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prerequisite to metastasis. Most clinical studies, so far, have focused on CTC 
enumeration in guiding prognosis in metastatic cancer patients and current 
research is exploring the pharmacodynamics and predictive biomarker utility 
of CTCs. In breast cancer, a quantity of CTCs ≥5 into 7.5 ml (0.7 CTCs/ml) is 
considered as an independent predictor for poor outcome in terms of 
progression-free survival41. 
Considering that an average adult has about 5 liters of blood circulating inside 
their body, 0.7 CTCs/ml means 3500 CTCs that, respect to a tumor composed 
by 108 cells, is the 0,0035%.  
Our percentages, although higher than those found in reality, show a similar 
trend. The differences can be traced back to the absence of the immune system 
in the in vitro system and, in general, to the preliminary phase of the study, 
which however results very promising. 
 
5.3.6.	RNA	analysis	
Single cell qPCR of the circulating LM2 cells was performed. The vast 
majority of cells gave no signal (this could be due to poor fitness of the cells): 
this is another remarkable result of the study, since preclinical models 
demonstrate that within 24 hours of intravenous administration of tumour 
cells, less than 0.1% cells remain viable and that less than 0.01% of these 
surviving CTCs can produce metastasis41. On the other side, other cells 
showed very good data. As example, a single LM2 circulating cell is reported: 
in this cell, we detected GAPDH, Vimentin and EGFR (all three well 
established markers of LM2) but not CD45 (white blood cell marker). This 
provides a proof-of-concept that the approach can work, as well as evidence 
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that the cells can be extracted from the device and used for molecular analysis. 
 
5.4.	References	
1 Fong, E. L., Santoro, M., Farach-Carson, M. C., Kasper, F. K. & 
Mikos, A. G. Tissue engineering perfusable cancer models. Current 
opinion in chemical engineering 3, 112-117 (2014). 
2 Hirt, C. et al. Bioreactor-engineered cancer tissue-like structures 
mimic phenotypes, gene expression profiles and drug resistance 
patterns observed “in vivo”. Biomaterials (2015). 
3 Wendt, D., Jakob, M. & Martin, I. Bioreactor-based engineering of 
osteochondral grafts: from model systems to tissue manufacturing. 
Journal of bioscience and bioengineering 100, 489-494 (2005). 
4 Orr, D. E. & Burg, K. J. L. Design of a modular bioreactor to 
incorporate both perfusion flow and hydrostatic compression for tissue 
engineering applications. Annals of biomedical engineering 36, 1228-
1241 (2008). 
5 Beachley, V. & Wen, X. Effect of electrospinning parameters on the 
nanofiber diameter and length. Materials Science and Engineering: C 
29, 663-668 (2009). 
6 Khil, M. S., Cha, D. I., Kim, H. Y., Kim, I. S. & Bhattarai, N. 
Electrospun nanofibrous polyurethane membrane as wound dressing. 
Journal of Biomedical Materials Research Part B: Applied 
Biomaterials 67, 675-679 (2003). 
7 Deitzel, J. M., Kleinmeyer, J., Harris, D. E. A. & Tan, N. C. B. The 
effect of processing variables on the morphology of electrospun 
nanofibers and textiles. Polymer 42, 261-272 (2001). 
8 Doerr, M. E. & Jones, J. I. The roles of integrins and extracellular 
matrix proteins in the insulin-like growth factor I-stimulated 
chemotaxis of human breast cancer cells. Journal of Biological 
Chemistry 271, 2443-2447 (1996). 
		 99	
9 Del Monte, U. Does the cell number 109 still really fit one gram of 
tumor tissue? Cell Cycle 8, 505-506 (2009). 
10 Krebs, M. G., Hou, J.-M., Ward, T. H., Blackhall, F. H. & Dive, C. 
Circulating tumour cells: their utility in cancer management and 
predicting outcomes. Therapeutic advances in medical oncology 2, 
351-365 (2010). 
11 Jeon, J. S., Zervantonakis, I. K., Chung, S., Kamm, R. D. & Charest, J. 
L. In vitro model of tumor cell extravasation. PloS one 8, e56910 
(2013). 
12 Ma, J. & Jemal, A. in Breast Cancer Metastasis and Drug Resistance     
1-18 (Springer, 2013). 
13 Bussard, K. M., Gay, C. V. & Mastro, A. M. The bone 
microenvironment in metastasis; what is special about bone? Cancer 
and Metastasis Reviews 27, 41-55 (2008). 
14 Zaman, M. H. The role of engineering approaches in analysing cancer 
invasion and metastasis. Nature Reviews Cancer 13, 596-603 (2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 100	
Chapter	6	
7 Discussion 
It is an established fact that 3D cultures are essential for a better 
comprehension of cell behaviour, as they recapitulate an environment more 
similar to the in vivo one. This is particularly important in pathological 
conditions, such as in cancer studies (e.g. breast cancer, the most common 
tumour in women), offering alternative approaches for the testing of new 
drugs; however, at the moment no established 3D models with clinically 
relevant size and features exist to carry out standardized and reproducible 
studies on breast cancer and, most importantly, on its metastatic spread. 
The availability of 3D models offering the appropriate in vitro 
microenvironment for cell tumour growth is essential to improve our 
knowledge of cancer biology and successfully test new anticancer 
compounds: animal models have proven to be not entirely compatible with 
the human system, and the success rate between animal and human studies 
is still unsatisfactory. On the other hand, 2D cell cultures are useful tools 
for cancer studies but they fail to reproduce some crucial aspects of 
tumours, such as 3D cell growth and cell-matrix interactions. These 
limitations have a significant weight especially during the screening of 
novel drugs, since it has been demonstrated that cells become less sensitive 
to anti-cancer treatments when in contact with their microenvironment. 
Thus, to obtain the same cancer cell inhibition level observed in vivo, the 
culture environment has to reflect the 3D natural environment, including its 
mechanical cues. Indeed, the biochemical (e.g. adhesiveness) and physical 
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properties (e.g. substrate stiffness) of the extracellular microenvironment 
have been recognized as independent factors that influence cell function 
and tissue morphogenesis in multiple ways41. Consequently, both 
categories must be considered when designing substrates for cell culture 
applications. 
In this context, the field of tissue engineering (TE) offers powerful tools to 
achieve 3D in vitro cancer models that are representative of in vivo solid 
tumours. Some TE-based cancer models have already been proposed, 
showing promising results in recapitulating several aspects of tumour 
microenvironment complexity16. Above all, natural or synthetic hydrogels 
reported successful outcomes in mimicking the ECM environment, thanks 
to their high water content and remarkable biocompatibility. In particular, 
Collagen I-based hydrogels showed promising angiogenic potential with a 
significant up-regulation of vascular endothelial growth factor (VEGF) 
gene expression, representative of the pre-vascularized stages of in vivo 
solid tumour progression42. Laminin-rich gels were adopted and validated 
as 3D platforms able to distinguish non-malignant versus malignant breast 
cells: when embedded in such gels, the non-malignant cells were organized 
into polarized colonies similar to mammary acini, while malignant cells 
lost cell polarity and underwent the disorganized growth typical of in vivo 
tumours43. 
However, in these studies, the tentative of reproducing the chemical 
features of the native ECM made the investigation of cell response to 
mechanical stimuli (mechano-responses) more complicated44. 
 
In the first work presented in this thesis (Chapter 3), I have realized and 
characterized 3D alginate-based hydrogels. Although alginate has already 
been demonstrated to be an excellent substrate for breast cancer cell 
culture45, I stressed the physical properties of alginate gels, including their 
stiffness, with the final aim of studying the effect of substrate elasticity on 
breast cancer cell activity (i.e. viability, proliferation and cluster 
formation). Alginate serves as a model, since its properties reflect those of 
many other gels. The following considerations, however, can be applied to 
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other polymers, being independent from the chemical properties of the 
substrates. The first step of this work was dedicated to definition of the 
parameters (Alginate percentage and cross-linker CaCl2 content) capable of 
modulating gel stiffness, quantified as elastic modulus. Among the 
techniques and laboratory instruments typically used for the mechanical 
characterization of 3D substrates, Atomic Force Microscopy (AFM) was 
chosen, since it allows measurement of hydrogel stiffness with a size-scale 
comparable to the cellular one, for a better understanding of the cell-
substrate stiffness interaction. Human breast cancer cells (MCF-7) were 
directly embedded within alginate gels with different elasticity, and 
cultured for up to 14 days. Cellular viability and cytoskeleton morphology 
were evaluated at early time points, since they are mostly a biological 
response to a specific event/environmental condition, e.g. substrate 
stiffness, chemical structure (plastic vs. alginate) and complexity (2D vs. 
3D). Cell proliferation and cluster formation were analysed at both 7 and 
14 days, in order to evaluate the progressive evolution of these processes 
within alginate-based gels. Remarkably, my results show that stiffness 
directly influences cells fate, not only in a 2D culture set-up as already 
demonstrated, but also in a more realistic 3D microenvironment where we 
observed a proportional elasticity-mediated cellular viability. In particular, 
I found that MCF-7s consistently proliferated in gels characterized by 
elastic moduli ranging between 150–200 kPa, until cell clusters of 100 μm- 
and 300 μm-diameters were obtained after 1 and 2 weeks, respectively. 
This uninhibited proliferative capacity, hereby observed in the softest gels, 
is one of the key stages that identifies the initial pre-vascularization and 
growth of solid tumours40,46. Additionally, the multicellular, cluster-like, 
conformation observed in 3D gels was much closer to in vivo solid tumour 
organization than the one seen in both 2D Petri and 2D-alginate cultures, 
thus demonstrating the benefit of 3D cancer models for reproducing cell-
cell and cell-matrix interactions47,48. As a consequence, I suggest that 
cellular morphology may be strongly affected by microenvironment 
dimensionality: tumour cells showed a flat morphology when expanded in 
2D cultures, where only a segment of the cell membrane can interact with 
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the substrate, while they exhibited a round shape in the 3D environment. In 
this condition, their proliferation strictly depends on substrate stiffness, 
which may affect the diffusion of nutrients and intracellular signalling 
through a mechano-transduction mechanism. 
Although the proposed in vitro breast cancer model specifically addresses 
the evaluation of cellular response to different substrate elasticity ranges 
and avoids the overall complex nature of the tumour microenvironment, 
some key characteristics of breast tumours, such as cluster organization and 
cellular morphology, have been successfully reproduced here. Therefore, it 
is desirable and expected that such a model could be enriched with further 
features (e.g. chemical and biological functionalization) to better emulate 
in vitro the natural tumour niche. These advanced models could be finally 
used for initial therapeutic screenings, e.g. evaluating if the administration 
of anticancer agents causes cell apoptosis or breaks cell proliferation as 
observed in successful in vivo chemotherapy treatments. 
 
 
In the work presented in Chapter 4, I presented new 3D models of highly 
aggressive breast cancer, allowing cells expressing some features 
characteristic of their aggressiveness and manifesting that capacity of motility 
at the base of the metastatic cascade. Invasiveness assays usually adopt a thin 
layer of reconstituted Matrigel in Boyden chambers as very rapid, easy and 
inexpensive test that can be used to detect the migratory activity associated 
with matrix degradation and quantify the invasive potential of cells 42. Because 
of the rapid degradation of Matrigel, this assay usually lasts few hours and 
Matrigel can't be used as 3D substrate maintaining cells entrapped in.  
From these starting considerations, the idea of new composites able to join the 
advantages of the two bulk materials was born, with the final aim to obtain a 
structurally performing and biologically permissive material to be used as 
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standard model for the 3D culture of aggressive breast cancer cells and for 
testing chemotherapeutic agents in vitro.  
To accomplish this, I first designed five different hydrogel compositions (i.e. 
100% A, 75%:25% A:M, 50%:50% A:M, 25%:75% A:M, 100% M), finally 
excluding 25%:75% A:M and 100% M because of a weak structural 
robustness and a low resistance in culture during the 7 days of culture. The 
remaining three categories were validated from a biological point of view, 
firstly assessing cell viability and proliferation both within the outer and inner 
parts of gels. Results show that cells were able to proliferate up to 4 times in 
all gel types; although cells within gels do not experience the same adhesion 
they have in 2D, it is known that tumour cells, and in particular MDA-MB-
231 cells, are resistance to anoikis43. The sight difference subsisting in favour 
of alginate substrates may be attributed to the capability of cancer cells to 
easily migrate within the Matrigel and thus to more easily escape from 
Matrigel-based gels. Confocal microscopy tools and 3D reconstruction 
techniques were used to analyse the morphological features of the cells, 
highlighting those differences related to their malignancy. 
I observed that cells maintained a spherical shape in 100% A gels, while they 
assumed elongated shape in presence of Matrigel; this last feature is in 
agreement with what is known in literature, according to which MDA-MB-
231 cells assume a particular stellate shape related to their malignancy. Cell 
elongation and cytoskeletal irregularity proportionally increased with the 
amount of Matrigel in the gels. In 50%:50% A:M gels, irregularity of the 
cytoskeleton is enhanced by the formation of invadopodia, actin-based 
protrusion of the plasma membrane through which cells anchor to the 
		 105	
extracellular matrix and degrade it. Remarkably, invadopodia was for the first 
time observed in a 3D in vitro model. Cell nuclei expressed irregular shape 
and poly-nuclei organization exclusively in cells with elongated shape and 
proportionally to the amount of Matrigel. This feature is known to be linked to 
cell malignancy as well, allowing us to say that 50%:50% A:M gels allow 
MDA-MB-231 cells to express those typical features of their aggressive in 
vivo behaviour. 
Finally, a bioreactor-based set-up for cell intravasation was adopted to monitor 
cell ability to migrate out from the gels. My results show that both in 
75%:25% A:M and in 50%:50% A:M cells were able to migrate through the 
gels, escape from them and adhere to a porous electrospun membrane 
functionalized with gelatine to promote cell attachment. 
These data, combined together, allows to say that a new 3D model of 
aggressive breast cancer (i.e. 50%:50% A:M) was provided. It is based on an 
hydrogel-based, 3D, culture method which allows human carcinomas to grow 
in vitro and to maintain many typical in vivo properties, including 3D 
architecture, poly-nuclei and invadopodia manifestation, expression of 
morphological differentiation and migration capability. Since we observed 
migration specifically into Matrigel containing networks, my data further 
suggest that cells interact actively with the matrix during dissemination. 
If a close mimicry of the in vivo situation is desired, it should be taken into 
account that tumours are 3D, auto-consistent structures and that metastatic 
cells actively escape from the primary tumour before entering in circulation. 
For this reason, standard microfluidic platforms and organ-on-chip 
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technologies, usually using free circulating cancer cells, are poorly 
representative of the human context. 
In conclusion, this 3D cell-laden hydrogel, combined with the presented 
bioreactor technology, is a good compromise between a reflection of the in 
vivo situation and manageable experimental effort, finally providing a 
revolutionary approach for studies on invasive breast cancer and drug testing.  
 
Finally, in Chapter 5 I focused on a new set-up for the observation of cancer 
cell motility and invasion. In particular, I combined a bioreactor-based 
bioengineering approach with single cell analysis of Circulating Tumor Cells 
(CTCs). Analysis of human CTCs has now revealed important features of 
cancer metastasis, such as the high metastatic potential of CTC-clusters 
compared to single CTCs, the dynamic expression of epithelial and 
mesenchymal markers on CTCs during treatment, and the possibility to culture 
CTCs from patients for a real-time and individualized testing of drug 
susceptibility. Nevertheless, several aspects of CTC biology remain unsolved, 
such as the characterization of the stem-like cell population among human 
CTCs. Defining the molecular features of those few metastasis-initiating, 
stem-like CTCs holds the exceptional promise to develop metastasis-tailored 
therapies for patients with cancer. 
For this reason, I applied the same approach to my in vitro system. Single cell 
qPCR of the circulating LM2 cells was performed. The vast majority of cells 
gave no signal (this could be due to poor fitness of the cells): this is another 
remarkable result of the study, since preclinical models demonstrate that 
within 24 hours of intravenous administration of tumour cells, less than 0.1% 
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cells remain viable and that less than 0.01% of these surviving CTCs can 
produce metastasis41. On the other side, other cells showed very good data. As 
example, a single LM2 circulating cell is reported: in this cell, we detected 
GAPDH, Vimentin and EGFR (all three well established markers of LM2) but 
not CD45 (white blood cell marker). This provides a proof-of-concept that the 
approach can work, as well as evidence that the cells can be extracted from the 
device and used for molecular analysis. 
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